
<html lang="en"     class="pb-page"  data-request-id="14630e24-d749-4105-8235-895f1036afc3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2008.51.issue-20;pageGroup:string:Publication Pages;article:article:10.1021/jm800598a;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1" /></meta><meta name="dc.Creator" content="Wieslaw M.  Kazmierski" /></meta><meta name="dc.Creator" content="Christopher  Aquino" /></meta><meta name="dc.Creator" content="Brian A.  Chauder" /></meta><meta name="dc.Creator" content="Felix  Deanda" /></meta><meta name="dc.Creator" content="Robert  Ferris" /></meta><meta name="dc.Creator" content="Deborah K.  Jones-Hertzog" /></meta><meta name="dc.Creator" content="Terrence  Kenakin" /></meta><meta name="dc.Creator" content="Cecilia S.  Koble" /></meta><meta name="dc.Creator" content="Christian  Watson" /></meta><meta name="dc.Creator" content="Pat  Wheelan" /></meta><meta name="dc.Creator" content="Hanbiao  Yang" /></meta><meta name="dc.Creator" content="Michael  Youngman" /></meta><meta name="dc.Description" content="We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the 125I-[MIP-1β] binding and Ba-L-HOS antiviral assays resulted in th..." /></meta><meta name="Description" content="We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the 125I-[MIP-1β] binding and Ba-L-HOS antiviral assays resulted in th..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800598a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800598a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800598a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800598a" /></link>
        
    
    

<title>Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800598a" /></meta><meta property="og:title" content="Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0015.jpeg" /></meta><meta property="og:description" content=" We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the 125I-[MIP-1β] binding and Ba-L-HOS antiviral assays resulted in the discovery of 64 and 68 in the 4,4-disubstitited piperidine class H, both potent CCR5 ligands (pIC50 = 8.30 and 9.00, respectively) and HIV-1 inhibitors (pIC50 = 7.80 and 7.84, respectively, in Ba-L-HOS assay). In addition, 64 and 68 were bioavailable in rodents, establishing them as lead molecules for further optimization toward CCR5 clinical candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800598a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800598a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800598a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800598a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800598a&amp;href=/doi/10.1021/jm800598a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 6538-6546</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8007739" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800670r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wieslaw+M.++Kazmierski">Wieslaw M. Kazmierski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Aquino">Christopher Aquino</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+A.++Chauder">Brian A. Chauder</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Deanda">Felix Deanda</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Ferris">Robert Ferris</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+K.++Jones-Hertzog">Deborah K. Jones-Hertzog</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrence++Kenakin">Terrence Kenakin</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cecilia+S.++Koble">Cecilia S. Koble</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Watson">Christian Watson</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pat++Wheelan">Pat Wheelan</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hanbiao++Yang">Hanbiao Yang</a></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Youngman">Michael Youngman</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 919-483-9462. Fax: 919-483-6053. E-mail: <a href="/cdn-cgi/l/email-protection#6d1a04081e010c1a430043060c170004081f1e06042d0a1e06430e0200"><span class="__cf_email__" data-cfemail="6e19070b1d020f19400340050f1403070b1c1d05072e091d05400d0103">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Infectious Diseases Center for Excellence in Drug Discovery, GlaxoSmithKline.</div><div class="corresp-fn" id="afn2">‡Molecular Discovery Research, GlaxoSmithKline.</div><div class="corresp-fn" id="afn3">§Computational & Structural Chemistry, GlaxoSmithKline.</div><div class="corresp-fn" id="afn4">∥Drug Discovery IT, GlaxoSmithKline.</div><div class="corresp-fn" id="afn5">⊥ID DMPK, GlaxoSmithKline.</div><div class="corresp-fn" id="afn6">#Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline.</div><div class="corresp-fn" id="afn7">∇Current address: Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800598a&amp;href=/doi/10.1021%2Fjm800598a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 6538–6546</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 May 2008</li><li><span class="item_label"><b>Published</b> online</span>24 September 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 October 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800598a" title="DOI URL">https://doi.org/10.1021/jm800598a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6538%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWieslaw%2BM.%2BKazmierski%252C%2BChristopher%2BAquino%252C%2BBrian%2BA.%2BChauder%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D20%26contentID%3Djm800598a%26title%3DDiscovery%2Bof%2BBioavailable%2B4%252C4-Disubstituted%2BPiperidines%2Bas%2BPotent%2BLigands%2Bof%2Bthe%2BChemokine%2BReceptor%2B5%2Band%2BInhibitors%2Bof%2Bthe%2BHuman%2BImmunodeficiency%2BVirus-1%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6546%26publicationDate%3DOctober%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800598a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2079</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800598a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wieslaw&quot;,&quot;last_name&quot;:&quot;M. Kazmierski&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Aquino&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;A. Chauder&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Deanda&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Ferris&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;K. Jones-Hertzog&quot;},{&quot;first_name&quot;:&quot;Terrence&quot;,&quot;last_name&quot;:&quot;Kenakin&quot;},{&quot;first_name&quot;:&quot;Cecilia&quot;,&quot;last_name&quot;:&quot;S. Koble&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Watson&quot;},{&quot;first_name&quot;:&quot;Pat&quot;,&quot;last_name&quot;:&quot;Wheelan&quot;},{&quot;first_name&quot;:&quot;Hanbiao&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Youngman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;6538-6546&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800598a&quot;},&quot;abstract&quot;:&quot;We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the 125I-[MIP-1β] binding and Ba-L-HOS antiviral assays resulted in the discovery of 64 and 68 in the 4,4-disubstitited piperidine class H, both potent CCR5 ligands (pIC50 = 8.30 and 9.00, respectively) and HIV-1 inhibitors (pIC50 = 7.80 and 7.84, respectively, in Ba-L-HOS assay). In addition, 64 and 68 were bioavailable in rodents, establishing them as lead molecules for further optimization toward CCR5 clinical candidates.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800598a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800598a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800598a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800598a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800598a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800598a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800598a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800598a&amp;href=/doi/10.1021/jm800598a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800598a" /></input><a href="/doi/pdf/10.1021/jm800598a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (293 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800598a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800598a%26sid%3Dliteratum%253Aachs%26pmid%3D18811134%26genre%3Darticle%26aulast%3DKazmierski%26date%3D2008%26atitle%3DDiscovery%2Bof%2BBioavailable%2B4%252C4-Disubstituted%2BPiperidines%2Bas%2BPotent%2BLigands%2Bof%2Bthe%2BChemokine%2BReceptor%2B5%2Band%2BInhibitors%2Bof%2Bthe%2BHuman%2BImmunodeficiency%2BVirus-1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D20%26spage%3D6538%26epage%3D6546%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the <sup>125</sup>I-[MIP-1β] binding and Ba-L-HOS antiviral assays resulted in the discovery of <b>64</b> and <b>68</b> in the 4,4-disubstitited piperidine class <b>H</b>, both potent CCR5 ligands (pIC<sub>50</sub> = 8.30 and 9.00, respectively) and HIV-1 inhibitors (pIC<sub>50</sub> = 7.80 and 7.84, respectively, in Ba-L-HOS assay). In addition, <b>64</b> and <b>68</b> were bioavailable in rodents, establishing them as lead molecules for further optimization toward CCR5 clinical candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The AIDS epidemic continues to be a significant global threat with 33 million individuals infected with HIV, about 4 million new infections each year, and about 2.9 million AIDS-related deaths every year. Highly active antiretroviral therapy (HAART<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: MIP-1β, macrophage inflammatory protein 1-β; CCR5, chemokine receptor 5; HOS, human osterosarcoma; HIV-1, human immunodeficiency virus-1; HAART, highly active antiretroviral therapy.</p></div> ) has been one of the key factors in a dramatic reduction of AIDS-related mortality rates, but there is still a continuing need for new medicines that address treatment complexity, high cost, unwanted side effects, drug−drug interactions, and viral resistance. In particular, anti-HIV drugs that exploit new mechanisms, such as inhibition of CCR5, are under intense development. Recent medicinal chemistry efforts have resulted in the discovery of several CCR5 antagonists currently in the clinic<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> and one FDA-approved drug for the treatment of ART-experienced patients.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Small molecule CCR5 inhibitors are allosteric ligands that, unlike the endogeneous CCR5 ligands, bind in a hydrophobic pocket inside CCR5, as demonstrated by single site mutagenesis studies with various small-molecule ligands. Progress in the discovery and development of CCR5 inhibitors has been summarized in recent reviews.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(4-12)</a></div><div class="NLM_p">In this report, we describe novel, small molecule CCR5 antagonists across eight chemical scaffolds. We pursued a modular, high-throughput chemistry approach by designing scaffolds with an amine and an aldehyde as points of diversity. Scaffolds were derivatized as amides/sulfonamides by reacting them with acyl chloride/sulfonyl chloride monomers, and as tertiary amines, by reductive alkylation with amine monomers, yielding putative CCR5 ligands (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). To aid monomer selection, a six-feature, pharmacophore model for CCR5 inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b) was constructed via Catalyst<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> from structure−activity data culled from both an in-house CCR5 binding HTS assay<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> as well as from external sources. A multidimensional BCUT chemistry space was also constructed from the same available data.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Both computer-assisted drug design (CADD) methods were then used to select reagents from our amine and acyl monomer sets. Monomers were selected on the basis of the pharmacophore model such that the Catalyst-derived scores were maximized for the resultant products. Monomers were also selected from the BCUT chemistry space such that the distances between the resultant products and known CCR5 antagonists were minimized.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Generalized modular structure of compounds described in this work. (b) Six-feature pharmacophore model for CCR5 antagonism constructed via Catalyst. Software version Catalyst v4.5, 2000, Accelrys, Inc., San Diego, CA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The scaffolds examined via the above computational approaches included <b>A</b>−<b>H</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref7 ref8 ref9 ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref16 ref17 ref18 ref19 ref20 ref21 ref22">(7-9, 16-22)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffolds <b>A</b>−<b>H</b> described in this work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of azetidine <b>A</b><a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16, 18)</a> was accomplished by sequentially alkylating 3,4-dichlorophenyl-acetonitrile with diethyl carbonate and then with 2-(2-bromoethyl)-1,3-dioxolane, resulting in <b>2</b> in 49% yield, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Catalytic hydrogenation of <b>2</b> and cyclization to <b>3</b> proceeded in a cumulative 59% yield. Finally, LAH-mediated reduction of <b>3</b> afforded the azetidine-based two-point diversity scaffold, which was subsequently derivatized to <b>4</b> and analogues (not shown), as described above.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a)Toluene, diethyl carbonate, NaH, reflux; (b) DMF, <i>t</i>-BuOK, 2-(2-bromoethyl)-1,3-dioxolane, −78 °C → rt, o/n; (c) MeOH/NH<sub>4</sub>OH, Ra−Ni, 60 psi H<sub>2</sub>, 50 °C; (d) THF/ethyl ether, CH<sub>3</sub>MgI, rt; (e) THF/ethyl ether, LAH, reflux; (f) THF, benzenesulfonyl chloride, DIEA; (g) 10% HCl in THF; (h) dichloroethane, 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, NaBH(OAc)<sub>3</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These azetidine-based analogues were found to exhibit low affinity to CCR5, with pIC<sub>50</sub> < 5.50 in the <sup>125</sup>I-[MIP-1β] binding assay.<a onclick="showRef(event, 'ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref18">(14, 18)</a></div><div class="NLM_p">We next synthesized 3-(alkyloxy)-3-phenyl-pyrrolidine <b>B</b> and 4-(alkyloxy)-4-phenyl-piperidine <b>C</b> scaffolds<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> by alkylating 1-(benzyl)-3-pyrroldinone and 1-(benzyl)-4-piperidinone with 4-bromo-1,2-dichlorobenzene, yielding <b>5a</b>,<b>b</b>. Oxidation of ethers <b>6a</b>,<b>b</b> afforded aldehyde scaffolds, which were subsequently derivatized to inhibitors <b>7−11</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a)THF, <i>t</i>-BuLi, −78 °C, 1-(benzyl)-3-pyrroldinone or 1-(benzyl)-4-piperidinone; (b) DMF, NaH, allyl bromide; (c) toluene, 1-chloroethyl chloroformate; (d) MeOH, K<sub>2</sub>CO<sub>3</sub>; (e) THF, (Boc)<sub>2</sub>O, TEA; (f) THF, OsO<sub>4</sub>, NMO; (g) THF/H<sub>2</sub>O, NaIO<sub>4</sub>; (h) DCE, amine, NaBH(OAc)<sub>3</sub>; (i) TFA/DCM (1/4); (j) DCM, acid chloride, polystyrene-DIEA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Potency pIC<sub>50</sub> of 4-(Alkyloxy)-4-phenylpyrrolidine (<b>B</b>) and 4-(Alkyloxy)-4-phenylpiperidine (<b>C</b>) Analogues <b>7−11</b> in the <sup>125</sup>I-[MIP-1β] Binding Assay</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0009.gif" alt="" id="gr6" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Compounds in both <b>B</b> and <b>C</b> classes also turned out to exhibit low affinity to CCR5. There was no scaffold ring-size effect when 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one amine-was employed in <b>7</b> and <b>9</b>. Similarly, the use of unsaturated acyl moiety in <b>10</b>, vs an aromatic one in <b>9</b>, did not affect binding. On the other hand, the SAR diverged between <b>B</b> and <b>C</b> when a sulfonamide moiety was employed, with potency of piperidine-based <b>8</b> being approximately 10-fold higher than that of pyrrolidine-based <b>11</b>.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">We next synthesized analogues in the pyrrolidinone <b>D</b> and pyrrolidine <b>E</b> scaffold series.<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16, 18)</a> Alkylation of 3,4-dichlorophenyl-acetonitrile with methyl bromoacetate yielded chromatographically separable bis-alkylated <b>12</b> (yield 35%) and monoalkylated <b>13</b> (yield 51%) applicable toward C2-<b>E</b> and C3-<b>E</b>, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Reduction and an in situ cyclization of <b>12</b> to pyrrolidinone <b>14</b> enabled synthesis of analogues <b>15−18</b> in the <b>D</b> and <b>E</b> series. Alkylation of <b>13</b> with 2-(3-bromopropoxy)-tetrahydro-2<i>H</i>-pyran afforded <b>20</b>, which after cyclization to <b>21</b> enabled C3-<b>E</b> analogues <b>22</b>−<b>26</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) THF, LHMDS, methyl bromoacetate, −78 °C, chromatographic separation; (b) MeOH, NH<sub>4</sub>OH, H<sub>2</sub>, 40 psi, Ra−Ni; rt; (c) THF, NaH, BnBr; (d) toluene, DIBAL; (e) DCE, amine, NaBH(OAc)<sub>3</sub>; (f) THF, LAH; (g) DMF, HATU, DIEA, acid; (h) DCM, Dess−Martin periodane; (i) THF, LHMDS, 2-(3-bromopropoxy)tetrahydro-2<i>H</i>-pyran; (j) 10% HCl in dioxane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Potency pIC<sub>50</sub> of Pyrrolidinone <b>D</b> (<b>15</b>, <b>16</b>), Pyrrolidine C2-<b>E</b> (<b>17</b>−<b>19</b>) and Pyrrolidine C3-<b>E</b> (<b>22</b>−<b>26</b>) Analogues in the <sup>125</sup>I-[MIP-1β] Binding Assay</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0010.gif" alt="" id="gr8" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Data in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> suggests that the C3-linker in the pyrrolidinone series <b>D</b> supports approximately 10-fold stronger binding than the C2-linker (<b>15</b> vs <b>16</b>, respectively). Similar trends can be observed in the pyrrolidine <b>E</b> series (<b>22</b> vs <b>17</b>). The 3,4-dichloro motif substantially increased potency compared to the unsubstituted phenyl ring, in both C2-<b>E</b> (<b>17</b> and <b>18</b>) and C3-<b>E</b> series (data not shown). Formal removal of the carbonyl moiety in <b>23</b> resulted in an approximately 40-fold potency decrease vs <b>22</b>, suggesting possible involvement of the carbonyl moiety in hydrogen bonding. Modifications in the 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one moiety were deleterious to potency in cyclohexyl <b>24</b>, hydantoine <b>25</b>, and <i>N</i>-Me <b>26</b> analogues, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Finally, the conformationally restricted <i>endo</i> tropane<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> moiety did not significantly influence the potency of <b>19</b> in the C2-<b>E</b> series, in contrast to a very significant effect of this moiety observed later in another scaffold (vide infra).</div><div class="NLM_p">We then examined the SAR and the potential to achieve strong binding to CCR5 in the piperidinone <b>F</b> and piperidine <b>G</b> scaffold families by synthesizing <b>29</b>,<b>30</b> and <b>32−34</b>.<a onclick="showRef(event, 'ref16 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref16 ref24 ref25 ref26">(16, 24-26)</a> Key intermediate <b>27</b>, obtained via a two-step alkylation of 3,4-dichlorophenyl-acetonitrile with 2-[(2-bromoethyl)oxy]tetrahydro-2<i>H</i>-pyran and ethyl acrylate,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> could then be either reduced to the piperidinone <b>28</b> or converted to the piperidine <b>31</b> by reduction and Mitsunobu cyclization, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) THF, NaH, Br-(CH<sub>2</sub>)<sub>3</sub>-O-THP; (b) dioxane, Triton B, ethyl acrylate; (c) MeOH, NH<sub>4</sub>OH, H<sub>2</sub>, 40 psi, Ra−Ni; rt; (d) THF, NaH, C<sub>6</sub>H<sub>5</sub>CH<sub>2</sub>Cl; (e) 10% HCl in THF; (f) DCM, MsCl, TEA; (g) DMSO, amines, 100 °C; (h) THF, LAH; (i) DCM, triphenyl phosphine, DEAD; (j) DCM, DIEA, C<sub>6</sub>H<sub>5</sub>COCl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Piperidine <b>G</b>-based inhibitors turned out to be more potent than piperidinone <b>F</b> analogues (<b>34</b> vs <b>29</b> and <b>33</b> vs <b>30</b>). As in other scaffold series examined, the 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one moiety in <b>34</b> and <b>29</b> resulted in superior binding (e.g., vs <b>33</b> and <b>30</b>), while the use of 4-(phenylamino)-4-piperidinecarboxamide in <b>32</b>, a formal ring-open homologue of <b>30</b>, resulted in a greater than 80-fold loss in potency, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Potency pIC<sub>50</sub> of Piperidones <b>F</b> and Piperidines <b>G</b> in the <sup>125</sup>I-[MIP-1β] Binding Assay</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0011.gif" alt="" id="gr9" /></img></td></tr></tbody></table></div></div><div class="NLM_p">The most potent ligand identified thus far, <b>22</b>, turned out to be a weak HIV inhibitor (binding pIC<sub>50</sub> = 6.85, antiviral pIC<sub>50</sub> = 5.2 in the Ba-L-HOS assay). While the cause of this discrepancy is under investigation, it is potentially caused by allosterism of <b>22</b>. Similar findings were reported for another class of CCR5 ligands,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> strongly suggesting that this effect is scaffold-related. We thus hypothesized that such discrepancy could be addressed with another scaffold and next explored the 4,4-disubstituted piperidines <b>H</b> series, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Because the SAR of the scaffolds examined thus far indicated significant phenyl ring substitution effects, we therefore developed several synthetic strategies (routes <b>A</b>−<b>C</b>), applicable to range of substituted phenyl and heteroaromatic rings, toward diverse aldehydes, exemplified here by <b>36</b>, <b>39</b>, and <b>43</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) THF, (Boc)<sub>2</sub>O, TEA; (b) toluene, DIBAL in toluene, −78 °C to −35 °C, 2.5 h; (c) THF, <i>t</i>-BuOK, methyloxymethyl triphenylphosphonium chloride, 0 to 60 °C over 2 h; (d) water/acetone, <i>p</i>-TsOH, rt; (e) DCM, Dess−Martin periodinane, <i>t</i>-BuOH, rt; (f) toluene, KHMDS, (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>NPh; (g) CH<sub>3</sub>CN, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, (CH<sub>3</sub>)<sub>2</sub>NH·BH<sub>3</sub>, 65 °C, sealed tube, overnight; (h) THF, 9-BBN, reflux, o/n; (i) NaOH aq, H<sub>2</sub>O<sub>2</sub>; (k) 1-chloro-3-iodobenzene, ethyl ether, magnesium turnings, rt, add to cyano(1-Boc-4-piperidinylidene)acetate in THF, CuI; (l) ethanol, sodium hydroxide, rt, 1 M HCl workup; (m) acetonitrile, Cu<sub>2</sub>O, reflux, 30 min; (n) DCM, −30 °C, DIBAL in DCM; (p) dichloroethane, sodium triacetoxyborohydride.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Aldehyde <b>39</b> was obtained by nitrile to aldehyde reduction in <i>N</i>-Boc-protected 4-(3,4-dichlorophenyl)-4-piperidinecarbonitrile (route <b>A</b>), followed by conversion to enolate <b>35</b>-<b>Cl</b>,<b>Cl</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. Chemoselective deprotection of the latter proved nontrivial, but after considerable exploration, <i>p</i>-toluenesulfonic acid was successfully employed, yielding <b>39</b>. The synthesis of <b>36</b> (route <b>C</b>) was accomplished in a cumulative 45% yield by reduction of triflate <b>37</b> to olefin <b>38</b>, followed by BBN-mediated hydroboration-hydroxylation and Dess−Martin oxidation. Aldehyde <b>36</b> was also independently obtained via route <b>A</b> from <b>35</b>-<b>H</b>,<b>H</b>. Finally, route <b>B</b>, applicable for large-scale synthesis of a range of aldehydes, employed conjugative addition of X-Ar-MgBr to cyano(1-Boc-4-piperidinylidene)acetate <b>40</b>, followed by hydrolysis and decarboxylation of cyanoester <b>41</b> (X = m-F). Resulting nitrile <b>42</b> was further reduced with DIBAL to <b>43</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a></div><div class="NLM_p">The C3 linker-containing scaffolds were accessed by nitrile reduction in N-Boc-protected 4-(3,4-X,X-phenyl)-4-piperidinecarbonitrile as in route <b>A</b>, followed by Horner−Emmons−Wadsworth olefination of thus resulting aldehydes and double bond reduction to yield esters <b>46</b> and <b>47</b>. DIBAL-mediated reduction and Dess−Martin oxidation was then used to secure <b>48</b> and <b>49</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) dichloromethane, (Boc)<sub>2</sub>O, TEA; (b) toluene, DIBAL in toluene, −78 °C to −35 °C, 2.5 h; (c) DMF, NaH, trimethylphosphonoacetate; (d) MeOH, H<sub>2</sub>, Pd−C, overnight; (e) toluene, DIBAL in toluene, −78 °C, 20 min; (f) DCM, Dess−Martin periodinane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogues <b>50</b>−<b>69</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) were synthesized from aldehydes <b>36</b>, <b>39</b>, <b>44</b>, <b>48</b>, and <b>49</b> and were then evaluated in the CCR5 <sup>125</sup>I-[MIP-1β] binding as well as HOS and PBL cell-based antiviral assays.<a onclick="showRef(event, 'ref14 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref14 ref30 ref31">(14, 30, 31)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Potency pIC<sub>50</sub> of C3-4,4-Disubstituted Piperidines <b>50</b>−<b>56</b> in the CCR5 <sup>125</sup>I-[MIP-1β] Binding Assay</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0012.gif" alt="" id="gr12" /></img></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Potency pIC<sub>50</sub> of Selected C2-4,4-Disubstituted Piperidines <b>57</b>−<b>62</b> in the CCR5 <sup>125</sup>I-[MIP-1β] Binding and Ba-L-HOS Antiviral Assay<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0013.gif" alt="" id="gr13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">n.t.: not tested.</p></div></div></div><div class="NLM_p">Significant differences emerged between the SAR in series <b>H</b> and previously discussed series. While pyrrolidine <b>E</b> and pyrrolidinone <b>D</b> series exhibited preference for the C3 linker, compounds in the C3-linker <b>H</b> class were found to exhibit low affinity to CCR5, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Furthermore, the use of the previously found preferred 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one moiety did not significantly improve the binding of <b>56</b> (e.g., vs <b>55</b>). Incorporation of the conformationally restricted 1-[(3-<i>exo</i>)-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-1<i>H</i>-benzimidazole moiety in <b>50</b> yielded an inactive analogue, although replacement of the carbamate with amide moieties in <b>52</b> and <b>53</b> resulted in some potency increase. Finally, in contrast to findings in scaffold <b>E</b>, there was no significant advantage of the 3,4-dichloro moiety on binding in series <b>H</b> (<b>55</b> vs <b>54</b> and <b>50</b> vs <b>51</b>), Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_p">Among the C2 linker-containing analogues <b>57−62</b>, many tropane-containing compounds, exemplified here by <b>57</b>, were found to be inactive. In addition, <b>58</b> was practically equipotent to its C3-analogue <b>56</b> and thus did not initially indicate any linker effect. However, unlike <b>50</b> (pIC<sub>50</sub> < 4.50) in the C3-series, the 1-[(3-<i>exo</i>)-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-1<i>H</i>-benzimidazole moiety in <b>59</b> in the C2-series resulted in moderate binding to CCR5 (pIC<sub>50</sub> = 7.2), corresponding to unexpectedly large (and reversed) linker effect (ΔpIC<sub>50</sub> (<b>59</b>−<b>50</b>)<sub>binding</sub> > 2.6). Similar trends were observed for amides <b>60</b> and <b>53</b> (ΔpIC<sub>50</sub> (<b>60</b>−<b>53</b>)<sub>binding</sub> = 1.55), which confirmed this surprising reversal of linker effect in scaffold <b>H</b> series (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) versus previous scaffolds.</div><div class="NLM_p">Encouraged by the potent binding of the <i>exo</i>-tropane <b>60</b>, we synthesized <i>endo</i>-tropanes <b>63−69</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. In particular, <b>64</b> was found to be a potent ligand (pIC<sub>50</sub> = 8.3) and antiviral (pIC<sub>50</sub> = 7.8 in the Ba-L-HOS assay), Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. This compound was inactive against HIV-1 pseudotyped with the G envelope glycoprotein of vesicular stomatitis virus (VSVg HIV), resulting in a VSVg/Ba-L selectivity ≥790, consistent with HIV inhibition through CCR5 (data not shown). As was found in the C3-<b>H</b> class, replacement of the carbamate moiety in <b>67</b> with amides in <b>66</b> and <b>63</b> improved binding and/or antiviral potency. To probe the influence of ring substitution on potency, we also synthesized and evaluated 3-Cl substituted analogues <b>65</b>, <b>68</b>, and <b>69</b>. Comparison of <b>69</b> to <b>67</b> and <b>68</b> to <b>66</b> suggested that 3-Cl substitution resulted in more potent analogues than the 3,4-di-Cl moiety, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibitory Potencies pIC<sub>50</sub> of <i>endo</i> C2-4,4-Disubstituted Piperidines <b>63</b>−<b>69</b> in the CCR5 <sup>125</sup>I-[MIP] Binding and Cellular Antiviral Assays<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0014.gif" alt="" id="gr14" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">n.t.: not tested.</p></div></div></div><div class="NLM_p">We further characterized <b>64</b> and <b>68</b> in rodent PK models. Inhibitor <b>64</b> had a moderate clearance in rats (22 mL/kg·min, 40% liver blood flow) and a dose-dependent bioavailability (<i>F</i> = 5%, 12.5%, and 19% at 1, 5, and 10 mg/kg oral doses, respectively). Inhibitor <b>64</b> also had a moderate clearance in mice (38 mL/kg·min, 42% liver blood flow) and dose-independent bioavailability <i>F</i> = 22%, 30%, and 20% at 1, 5, and 10 mg/kg oral dose, respectively. Similarly, rat clearance (21 mL/kg·min, 38% liver blood flow) and bioavailability of inhibitor <b>68</b> at 1 mg/kg oral dose (<i>F</i> = 26%) were quite encouraging.</div><div class="NLM_p last">In summary, our investigation of the SAR of scaffolds <b>A</b>−<b>G</b> revealed a preference for the C3 linker and the 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). There was no significant effect on potency when 1-[(3-<i>endo</i>)-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-1<i>H</i>-benzimidazole was incorporated in <b>19</b> in class <b>E</b>. The 3,4-dichloro phenyl moiety also provided a significant potency advantage versus unsubstituted phenyl in both C2-<b>E</b> and C3-<b>E</b>. These findings contrasted with SAR in scaffold <b>H</b>. There, key structural contributors to binding, exemplified by potent inhibitors <b>60</b>, <b>64</b>, and <b>68</b>, were both the C2 linker and 1-[(3-<i>endo</i> or <i>exo</i>)-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-1<i>H</i>-benzimidazole moiety. In addition, there was no substantial influence of the 3,4-dichloro phenyl moiety on binding, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. This work utilized high-throughput modular chemistry approach, with monomers optimized for best fit to accelerate discovery of potent ligands. We were able to rapidly evaluate and evolve scaffolds toward ones supporting increased potency, culminating in discovery of novel and potent HIV-1 CCR5 inhibitors <b>64</b> and <b>68</b>. In addition, <b>64</b> and <b>68</b> demonstrated promising PK in rodents, supporting further lead optimization of scaffold <b>H</b> toward clinically viable candidate molecules.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless stated otherwise, the reagents were obtained from commercial sources and were used directly. Reactions involving air- or moisture-sensitive reagents were carried out under a nitrogen atmosphere. The reactions were carried out at ambient temperature unless otherwise indicated. Silica gel (EM Science, 230−400 mesh) was used for chromatographic purification unless otherwise indicated. Anhydrous solvents were obtained from Aldrich (Sure Seal). <sup>1</sup>H NMR spectra were recorded on a Varian 300 or 400 MHz spectrometers; the chemical shifts are reported in parts per million (ppm) relative to TMS. The following abbreviations are used to describe peak patterns when appropriate: b = broad, s = singlet, d = doublet, t = triplet, q = quartet, and m = multiplet. <sup>1</sup>H NMR analyses were carried out in deuterated chloroform unless otherwise indicated. Mass spectra (ms) were obtained using electrospray (positive or negative ion).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Synthesis of Inhibitors <b>53</b>, <b>55</b>, <b>60</b>, <b>62</b>, <b>63</b>, <b>66</b>, <b>64</b>, <b>68</b>, and <b>69</b> and of Key Intermediates</h3><div class="NLM_p">(a) Compound <b>40</b>. A mixture of <i>tert</i>-butyl 4-oxo-1-piperidinecarboxylate (25.25 g, 127 mmol), ethyl cyanoacetate (13.8 mL, 130 mmol), ammonium acetate (2.73 g, 35.4 mmol), glacial acetic acid (6.3 mL), and benzene (250 mL) was heated for 4 h at reflux under Dean−Stark conditions. The reaction mixture was cooled to room temperature and washed successively with water, sodium bicarbonate solution, and brine. Drying, filtration, and evaporation of the organic phase provided <i>tert-</i>butyl 4-(1-cyano-2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate as an oil that crystallized on standing (37 g, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.28 (q, 2H, <i>J</i> = 7 Hz), 3.60 (br t, 2H, <i>J</i> = 6 Hz), 3.54 (br t, 2H, <i>J</i> = 6 Hz), 3.12 (t, 2H, <i>J</i> = 6 Hz), 2.76 (t, 2H, <i>J</i> = 6 Hz), 1.47 (s, 9H), and 1.35 (t, 3H, <i>J</i> = 7 Hz). ES-LCMS <i>m</i>/<i>z</i> 293 (M − 1).</div><div class="NLM_p">(b) Compound <b>41</b>. A solution of 1-chloro-3-iodobenzene (14.1 g, 59.28 mmol) in diethyl ether (12 mL) was added dropwise to a mixture of magnesium turnings (1.59 g, 65.4 mmol) in diethyl ether (50 mL) at room temperature. When the Grignard reaction was complete, the resulting organomagnesium reagent was added dropwise to a stirred mixture of <b>40</b> (5.0 g, 17 mmol) and cuprous iodide (800 mg, 4.2 mmol) in tetrahydrofuran (30 mL) cooled to 0 °C. The reaction mixture was stirred 1 h at 0 °C and then quenched with saturated ammonium chloride solution. Ethyl acetate (500 mL) was added, and the mixture was washed successively with saturated ammonium chloride, water, and brine. The organic layer was dried and concentrated, and the resulting crude material was purified by column chromatography on silica gel eluting with 4:1 hexane:ethyl acetate. This afforded <i>tert-</i>butyl 4-(3-chlorophenyl)-4-(1-cyano-2-ethoxy-2-oxoethyl)piperidine-1-carboxylate <b>41</b> as an oil (5.2 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37−7.26 (m, 4H), 3.99 (br q, 2H, <i>J</i> = 6 Hz), 3.91 (br m, 2H), 3.58 (s, 1H), 2.88 (br m, 2H), 2.52 (ddd, 2H, <i>J</i> = 6, 4, 3 Hz), 2.04 (m, 2H), 1.43 (s, 9H), and 1.06 (t, 3H, <i>J</i> = 6 Hz). ES-LCMS <i>m</i>/<i>z</i> 429 (M + Na<sup>+</sup>).</div><div class="NLM_p">(c) Compound <b>42</b>. Four M aqueous sodium hydroxide (30 mL, 120 mmol) was added to solution of <b>41</b> (5.2 g, 12.8 mmol) in ethanol (30 mL). After stirring at room temperature for 6.5 h, concentrated HCl was added dropwise at 0 °C to reach pH ∼ 4. The mixture was then subjected to ethyl acetate/water extraction, organic phases collected, and concentrated to afford [1-(<i>tert</i>-butoxycarbonyl)-4-(3-chlorophenyl) piperidin-4-yl](cyano)acetic acid as a foam (3.75 g, 77%). This material (used without further purification) was dissolved in acetonitrile (30 mL), and cupric oxide (355 mg, 0.025 mmol) was added. The mixture was heated at reflux with stirring for 30 min and then cooled to room temperature, filtered through celite, and evaporated to give <i>tert-</i>butyl 4-(3-chlorophenyl)-4-(cyanomethyl)piperidine-1-carboxylate <b>42</b> (3.0 g, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37−7.27 (m, 4H), 3.74 (br m, 2H), 3.08 (br t, 2H, <i>J</i> = 11 Hz), 2.55 (s, 2H), 2.27 (br dd, 2H, <i>J</i> = 11, 3 Hz), 1.86 (ddd, 2H, <i>J</i> = 14, 11, 4 Hz), and 1.44 (s, 9H).</div><div class="NLM_p last">(d) Compound <b>43</b>. A solution of <b>42</b> (1.96 g, 5.85 mmol) in dichloromethane (25 mL) was cooled to −30 °C, and a 1 M solution of diisobutyl aluminum hydride in dichloromethane (15.5 mL, 17.5 mmol) was added dropwise at-35 °C. The reaction mixture was stirred 30 min and then quenched at −35 °C with methanol (0.7 mL) followed by saturated citric acid solution (50 mL), allowed to warm to room temperature, and extracted with dichloromethane. Combined dichloromethane layers were dried, filtered, and evaporated to provide <i>tert</i>-butyl 4-(3-chlorophenyl)-4-(2-oxoethyl)piperidine-1-carboxylate <b>43</b> as an oil (1.3 g, 66%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.40 (t, 1H, <i>J</i> = 3 Hz), 7.34−7.22 (m, 4H), 3.61 (m, 2H), 3.26 (ddd, 2H, <i>J</i> = 13, 9, 3 Hz), 2.66 (d, 2H, <i>J</i> = 3 Hz), 2.19 (m, 2H), 1.86 (ddd, 2H, <i>J</i> = 13, 9, 3 Hz), and 1.44 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 201.4 (CH), 154.97 (C), 145.8 (C), 135.2 (C), 130.4 (CH), 127.3 (CH), 127.0 (CH), 124.9 (CH), 79.9 (C), 54.6 (2CH<sub>2</sub>), 53.3 (C), 39.2 (CH<sub>2</sub>), 35.5 (2CH<sub>2</sub>), and 28.6 (3CH<sub>3</sub>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthesis of Aldehyde <b>36</b>: Vinyl Enolate Route A</h3><div class="NLM_p">(a) Triethylamine (95 mL) was added to a suspension of 4-cyano-4-phenylpiperidine hydrochloride (50.4 g, 0.266 mol) in tetrahydrofuran (440 mL), followed by di-<i>tert</i>-butyl dicarbonate (47.95 g, 0.22 mol) in tetrahydrofuran (150 mL). After stirring at room temperature for 2 h, 200 mL of ethyl acetate was added and washed with 200 mL of 1N citric acid, 200 mL of brine, dried over sodium sulfate, and concentrated to yield 1-Boc-4-phenyl-4-piperidinecarbonitrile (64.40 g, 99%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.51−7.34 (m, 5H), 4.33−4.18 (m, 2H), 3.27−3.19 (m, 2H), 2.14−1.92 (m, 4H), and 1.51 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 308 (M + H).</div><div class="NLM_p">(b) A 1 M solution of diisobutylaluminum hydride in toluene (248 mL) was added over 3 h to a solution of 33.32 g (0.116 mol) of 1-Boc-4-phenyl-4-piperidinecarbonitrile (procedure a) in toluene (600 mL) at −78 °C. The reaction mixture was allowed to warm up to −35 °C over 2 h and stirred at −35 °C for 1 h. After quenching with methanol, aqueous workup yielded 29.71 g (88%) of the 1-Boc-4-phenyl-4-piperidinecarbaldehyde. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.43 (s, 1H), 7.55−7.18 (m, 5H), 3.92−3.82 (m, 2H), 3.31−3.18 (m, 2H), 2.40−1.92 (m, 4H), and 1.38 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 290 (M + H).</div><div class="NLM_p">(c) A 1 M solution of potassium <i>tert</i>-butoxide in tetrahydrofuran (22 mL) was added dropwise to a slurry of (methoxymethyl)triphenyl-phosphonium chloride (7.39 g, 21.56 mmol) in tetrahydrofuran (90 mL) and the reaction mixture was stirred at room temperature for 30 min, followed by addition of the solution of 6.24 g, (21.56 mmol) 1-Boc-4-phenyl-4-piperidinecarbaldehyde (step b) in tetrahydrofuran (18 mL). The mixture was stirred at room temperature for 16 h, heated to reflux for 2 h. Aqueous workup and silica gel chromatography afforded 4.64 g, (68%) of <b>35</b>-<b>H</b>,<b>H</b> as a 1:1 mixture of <i>E/Z</i> isomers. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.51−7.19 (m, 5H), 6.07 and 4.84 (d, <i>J</i> = 13.0 Hz, 1H), 5.95 and 4.23 (d, <i>J</i> = 7.1 Hz, 1H), 3.95−3.78 (m, 2H), 3.54 and 3.51 (s, 3H), 3.30−3.06 (m, 2H), 2.20−2.09 (m, 2H), 1.98−1.76 (m, 2H), and 1.52 and 1.49 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 318 (M + H).</div><div class="NLM_p last">(d) Compound <b>36</b>. Solution of <i>p</i>-toluenesulfonic acid monohydrate (1.95 g, 10.28 mmol) in water (24 mL) was added to solution of <b>35−H</b>,<b>H</b> (4.64 g, 14.61 mmol) in acetone (48 mL) and reaction stirred at room temperature for 48 h. After acetone was removed, solid sodium bicarbonate was added until pH 9, and the aqueous layer extracted with several volumes of DCM and organic fractions were combined and then dried over sodium sulfate. After silica gel purification, 2.23 g of <b>36</b> (50%) was obtained. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.39 (s, 1H), 7.43−7.25 (m, 5H), 3.69−3.61 (m, 2H), 3.31−3.22 (m, 2H), 2.65 (s, 2H), 2.28−2.23 (m, 2H), 1.92−1.83 (m, 2H), and 1.46 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 304 (M + H).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis of <b>44</b>, <i>endo</i>-1-(8-Azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3><div class="NLM_p">(a) <i>endo</i>-1,1-Dimethylethyl 3-[(phenylmethyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate. Sodium triacetoxyborohydride (125 g, 0.59 mol) was added portionwise during 45 min to a mechanically stirred mixture of <i>tert</i>-butyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate (88.3 g, 0.39 mol), pulverized 4A molecular sieves (88 g), and benzylamine (44.1 g, 0.41 mol) in dichloromethane (1 L) at rt under N<sub>2</sub>. The mixture was stirred at rt for 2 days. Saturated sodium carbonate solution (1 L) was added, the mixture stirred for 1 h at room temperature, filtered, and the aqueous layer was further extracted with dichloromethane, and combined organic layers were dried and concentrated to a white solid endo 1,1-dimethylethyl 3-[(phenylmethyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate (123 g, 99%). <sup>1</sup>H NMR (400 MHz; CDCl<sub>3</sub>) δ 7.24−7.33 (m, 5H), 4.19 (m, 1H), 4.10 (m, 1H), 3.76 (s, 2H), 3.00 (t, 1H), 2.15 (m, 3H), 1.91 (m, 2H), 1.60 (m, 1H), 1.57 (m, 1H), 1.49 (m, 1H), 1.48 (m, 1H), 1.45 (s, 9H). AP-LCMS <i>m</i>/<i>z</i> 317 (M + 1).</div><div class="NLM_p">(b) <i>endo</i>-1,1-Dimethylethyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate. A stirred mixture of 123 g (0.39 mol) of endo 1,1-dimethylethyl 3-[(phenylmethyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate (section a), ammonium formate (175 g, 2.78 mol), and 20% palladium hydroxide on carbon (12.3 g) in absolute ethanol (1.5 L) was heated to 50 °C under nitrogen for 7 h. The mixture was filtered and the filtrate was concentrated, dissolved in ethyl acetate, and was washed with water, dried, and concentrated to give the desired <i>endo</i>-1,1-dimethylethyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate product (65.4 g, 74%). <sup>1</sup>H NMR (400 MHz; CDCl<sub>3</sub>) δ 4.19 (m, 1H), 4.10 (m, 1H), 3.30 (t, 1H), 3.03−2.19 (m, 4H), 1.94 (m, 2H), 1.58 (m, 2H), 1.44 (s, 9H). AP-LCMS <i>m</i>/<i>z</i> 127 (M-99).</div><div class="NLM_p">(c) <i>endo</i>-<i>t</i>-Butyl 3-[(2-Nitrophenyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate). A mixture of 65.4 g (0.29 mol) of <i>tert</i>-butyl-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate (section b), <i>N,N</i>-diisopropylethylamine (56 mL, 0.32 mol) and 1-fluoro-2-nitrobenzene (40.9 g, 0.29 mol) in 1-methyl-2-pyrrolidinone (200 mL) was heated at 70 °C under nitrogen for 16 h. The reaction mixture was diluted with water (500 mL) and extracted with ethyl acetate (3 × 300 mL), and combined organic layers dried and purified on silica gel to give the desired endo-<i>tert</i>-butyl 3-[(2-nitrophenyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate derivative (98.2 g, 98%). <sup>1</sup>H NMR (400 MHz; CDCl<sub>3</sub>) δ 8.74 (m, 1H), 8.18 (m, 1H), 7.43 (m, 1H), 6.61−6.73 (m, 2H), 4.26 (m, 2H), 3.90 (t, 1H), 2.26−2.32 (m, 2H), 2.03 (m, 4H), 1.83 (m, 2H), 1.44 (s, 9H).</div><div class="NLM_p">(d) <i>endo</i>-<i>t</i>-Butyl 3-[(2-Aminophenyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate. A mixture of 98.2 g (0.28 mol) of <i>tert</i>-butyl-3-[(2-nitrophenyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate (procedure c), 10% Pd/C (10 g) in ethanol:ethyl acetate 1:1 (1 L) was hydrogenated for 24 h at atmospheric pressure (uptake 17.4 L). The mixture was filtered through celite and concentrated to give the title product (76.2 g, 86%). <sup>1</sup>H NMR (400 MHz; CDCl<sub>3</sub>) δ 6.67−6.83 (m, 3H), 6.57 (m, 1H), 4.25 (m, 1H), 4.17 (m, 1H), 3.70 (m, 2H), 3.32 (br s, 2H), 2.28 (m, 2H), 1.98−2.07 (m, 4H), 1.76 (m, 2H), 1.47 (s, 9H). AP-LCMS <i>m</i>/<i>z</i> 318 (M + 1).</div><div class="NLM_p last">(e) <i>endo</i>-1-(8-Azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole hydrochloride <b>44</b>. A solution of 76.2 g (0.24 mol) of <i>tert</i>-butyl 3-[(2-aminophenyl) amino]-8-azabicyclo[3.2.1]octane-8-carboxylate (obtained in procedure d) in triethylorthoacetate (250 mL) was refluxed under nitrogen for 2.5 h. The mixture was concentrated, redissolved in ethyl acetate (500 mL), washed with water (2 × 200 mL), washed with brine, dried, and concentrated. The residue was dissolved in ethanol (250 mL), 6N hydrochloric acid (200 mL) was added and the mixture was refluxed for 2 h. The reaction mixture was concentrated to the desired title product (61.5 g, 92%). <sup>1</sup>H NMR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 10.16 (d, <i>J</i> = 10 Hz, 1H), 9.47 (d, <i>J</i> = 10 Hz, 1H), 7.95 (d of d, <i>J</i> = 3.6 Hz, 1H), 7.79 (d of d, <i>J</i> = 4.8 Hz, 1H), 7.54 (m, 2H), 5.63 (m, 1H), 4.13 (d, <i>J</i> = 9 Hz, 2H), 2.88 (s, 3H), 2.71 (m, 2H), 2.17 (m, 6H). ES-LCMS <i>m</i>/<i>z</i> 242 (M + 1).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>45</b>: <i>exo</i>-1-(8-Azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3><div class="NLM_p">(a) 8-Benzyl-8-azabicyclo[3.2.1]octan-3-one. First, 60 g (454 mmol) of 2,5-dimethoxytetrahydrofuran was added to 192 mL of 0.025 M HCl at 0 °C and the mixture was stirred at 0 °C for 17 h. Then 78 g (543.6 mmol) of benzyl amine, 66 g (452.0 mmol) of 3-oxopentanedioic acid, and 20.4 g (248.4 mmol) of sodium acetate in 360 mL of water were sequentially added at 0 °C. The reaction was allowed to proceed at room temperature for 1 h, then heated to 50 °C for 2 h, cooled to ambient temperature, pH adjusted to 12, product extracted with ethyl acetate (×3), dried, and solvents removed. Distillation at ∼120 °C yielded 25 g of the title crude product.</div><div class="NLM_p">(b) 8-Benzyl-8-azabicyclo[3.2.1]octan-3-one oxime. To 4.85 g (22.56 mmol) of 8-benzyl-8-azabicyclo[3.2.1]octan-3-one (from step a) was dissolved in 60 mL of ethanol, and 3.13 g (45 mmol) hydroxylamine hydrochloride was added, followed by the addition of 1.8 g (45 mmol) of NaOH in 15 mL water. The mixture was refluxed for 20 h and solvents removed in vacuo to give 4.28 g of the product.</div><div class="NLM_p">(c) <i>exo</i>-8-Benzyl-8-azabicyclo[3.2.1]octan-3-amine. First 3.5 g of sodium in 200 mL of pentanol was added portionwide over 1 h to 3.9 g (16.9 mmol) of 8-benzyl-8-azabicyclo[3.2.1]octan-3-one oxime (step b). The mixture was then refluxed for 3 h, cooled to ambient temperature, quenched with water, and extracted with 6N HCl. The aqueous layer was basified using NaOH pellets and the compound extracted with EtOAc, the organic layer dried, and solvents removed to afford 2.9 g (80%) of crude title product.</div><div class="NLM_p">(d) <i>exo</i>-8-Benzyl-<i>N</i>-(2-nitrophenyl)-8-azabicyclo[3.2.1]octan-3-amine. First 4.32 g (30.60 mmol) 1-fluoro-2-nitrobenzene was added to 5.62 g (27.82 mmol) of exo-8-benzyl-8-azabicyclo[3.2.1]octan-3-amine (from step c) and 9.7 mL (55.46 mmol) of Hunig base dissolved in 200 mL of NMP. Then the mixture was stirred at RT for 3 h, diluted with EtOAc, washed with water, the organic layer dried, and solvents removed, affording 8.62 g of the title product.</div><div class="NLM_p">(e) <i>exo</i>-<i>N</i>-(8-Benzyl-8-azabicyclo[3.2.1]oct-3-yl)benzene-1,2-diamine. To 2.92 g (9.04 mmol) of <i>exo</i>-8-benzyl-<i>N</i>-(2-nitrophenyl)-8-azabicyclo[3.2.1]octan-3-amine (procedure d) dissolved in 150 mL of EtOAc and 25 mL of methanol, 1 g Pd/C was added and the mixture stirred at 1 atm H<sub>2</sub> for 3.5 h, filtered through celite, and solvents removed to afford 2.2 g of the desired solid.</div><div class="NLM_p">(f) <i>exo</i>-1-(8-Benzyl-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole. First 7.7 g (25.08 mmol) of <i>exo</i>-<i>N</i>-(8-benzyl-8-azabicyclo [3.2.1]oct-3-yl)benzene-1,2-diamine (procedure e) was refluxed in 200 mL of 1,1,1-triethoxyethane for 18 h. The mixture was cooled, solvents removed, and the residue redissolved in toluene, 1.8 g (9.47 mmol) of <i>p</i>-toluenesulfonic acid was added, and the reaction mixture was heated to reflux for 18 h. Purification resulted in 2.2 g of the desired product.</div><div class="NLM_p last">(g) <i>exo</i>-1-(8-Azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole <b>45</b>. First 2.2 g (6.65 mmol) of <i>exo</i>-1-(8-benzyl-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole (procedure f) was dissolved in 150 mL of ethanol, followed by addition of 2.09 g (33.23 mmol) of ammonium formate and 0.4 g palladium hydroxide (20% on carbon), and the mixture was refluxed for 2.5 h and filtered through celite to yield after solvent removal 1.06 g of the desired product <b>45</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.65 (m, 1H), 7.55 (m, 1H), 7.20 (m, 2H), 4.52 (m, 1H), 3.72 (m, 2H), 2.65 (s, 3H), 2.50 (m, 2H), 1.96 (m, 2H); 1.80 (m, 4H).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>69</b></h3><div class="NLM_p last">(a) <i>tert</i>-Butyl <i>endo</i>-4-(3-chlorophenyl)-4-{2-[3-(2-methyl-1<i>H</i>-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}piperidine-1-carboxylate. Sodium triacetoxyborohydride (286 mg, 1.35 mmol) was added in one portion to a stirred mixture of the dihydrochloride salt of <b>44</b> (250 mg, 0.90 mmol), <b>43</b> (304 mg, 0.90 mmol), triethylamine (0.25 mL, 1.79 mmol), and powdered sieves (250 mg) in dichloromethane (3 mL). After stirring for 1 h at room temperature, the reaction was quenched with saturated sodium bicarbonate solution and the dichloromethane layer was removed. The aqueous layer was extracted with dichloromethane and after workup afforded <i>tert-</i>butyl <i>endo-</i>4-(3-chlorophenyl)-4-{2-[3-(2-methyl-1<i>H</i>-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}piperidine-1-carboxylate <b>69</b> (500 mg, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.47 (dd, 1H, <i>J</i> = 7.2 Hz), 7.40 (br s, 1H), 7.39−7.35 (m, 3H), 7.27 (d, 1H, <i>J</i> = 7 Hz), 7.11 (dd, 1H, <i>J</i> = 7.6 Hz), 7.08 (dd, 1H, <i>J</i> = 7.6 Hz), 4.50 (m, 1H, <i>J</i> = 8 Hz), 3.48 (m, 2H), 3.24 (m, 2H), 3.11 (m, 2H), 2.48 (s, 3H), 2.35 (br dd, 2H, <i>J</i> = 15.9 Hz), 1.98 (m, 2H), 1.90−1.70 (m, 10H), 1.59 (d, 2H, <i>J</i> = 8 Hz), and 1.36 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 585 (M + Na<sup>+</sup>).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>68</b>, <i>endo</i>-1-(8-{2-[4-(3-Chlorophenyl)-1-(2,2-dimethylpropanoyl)piperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Deprotection</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">First, 4 M HCl in dioxane (7 mL, 28 mmol) was added to a stirred solution of <b>69</b> (500 mg, 0.888 mmol) in dichloromethane (6 mL). After 15 min, solvents were removed, affording <i>endo-</i>1-(8-{2-[4-(3-chlorophenyl)piperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole dihydrochloride (548 mg, 100%). This material was used without further purification. ES-LCMS <i>m</i>/<i>z</i> 463 (M + H).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Amide Formation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Pivaloyl chloride (0.040 mL, 0.325 mmol) was added to the solution of <i>endo-</i>1-(8-{2-[4-(3-chlorophenyl)piperidin-4-yl]ethyl}-8-azabicyclo [3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole dihydrochloride (165 mg, 0.308 mmol) and triethylamine (0.086 mL, 0.616 mmol) in dichloromethane (3 mL). After stirring 1 h at room temperature, the reaction mixture was quenched with saturated sodium bicarbonate solution and after aqueous workup and purification on silica gel gave <i>endo-</i>1-(8-{2-[4-(3-chlorophenyl)-1-(2,2-dimethylpropanoyl)piperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole <b>68</b> (100 mg, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.48 (d, 1H, <i>J</i> = 7 Hz), 7.42 (s, 1H), 7.41−7.34 (m, 3H), 7.28 (d, 1H, <i>J</i> = 7 Hz), 7.11 (br t, 1H, <i>J</i> = 7 Hz), 7.08 (br t, 1H, <i>J</i> = 7), 4.50 (m, 1H, <i>J</i> = 8 Hz), 3.73 (m, 2H), 3.29 (s, 3H), 3.25 (m, 4H), 2.35 (br dd, 2H, <i>J</i> ∼ 22.9 Hz), 2.02 (m 2H), 1.84−1.73 (m, 10H), 1.59 (d, 2H, <i>J</i> = 8 Hz), and 1.16 (s, 9H). ES-LCMS <i>m</i>/<i>z</i> 547 (M + H). HRMS C<sub>33</sub>H<sub>43</sub>ClN<sub>4</sub>O <i>m</i>/<i>z</i> 547.3186 (M + H)<sub>calcd</sub> 547.3204 (M + H)<sub>obs</sub>.</div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_1"><div id="ac_i17" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i17"> </h2><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Compound <b>64</b></h3><div class="NLM_p">(a) <i>endo</i>-2-Methyl-1-((1<i>R</i>,5<i>S</i>)-8-{2-[4-phenyl-1-(phenylcarbonyl)-4-piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-1<i>H</i>-benzimidazole Compound <b>64</b> was obtained from intermediates <b>36</b> and <b>44</b> using the procedure described for <b>68</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20 (1H, m), 6.94 (7H, m), 6.82 (4H, m), 6.70 (2H, m), 4.15 (1H, m), 3.75 (1H, m), 3.11 (1H, m), 2.98 (4H, m), 2,93 (1H, m), 2.78 (3H, m), 2.05 (3H, s), 2.04 (2H, m), 1.88 (3H, m), 1.70 (1H, m), 1.59−1.24 (4H, m), 1.14 (2H, m). HRMS <i>m</i>/<i>z</i> (M + H)<sup>+</sup><sub>calcd</sub> 533.3280; (M + H)<sup>+</sup><sub>obs</sub> 533.3300.</div><div class="NLM_p last">Alternatively, <b>64</b> was synthesized by reductive alkylation of <b>44</b> with (1-benzoyl-4-phenylpiperidine-4-yl) acetaldehyde using the procedure described for <b>69</b>. To that end, the synthesis of (1-benzoyl-4-phenylpiperidine-4-yl) acetaldehyde was accomplished by stirring 4 M HCl in dioxane (9 mL) and <b>36</b> (8.75 g, 27.57 mmol) in THF (27 mL) for 1 h at rt. The solvents were evaporated and product redissolved in DCM (40 mL), cooled to 0 °C, and benzoyl chloride (4.65 g, 33.08 mmol) in DCM (5 mL) was added, followed by triethylamine 8.37 g, 82.71 mmol) in DCM (5 mL). After stirring for 1 h at rt, aqueous workup and silica gel chromatography afforded the desired (1-benzoyl-4-phenylpiperidine-4-yl) acetaldehyde (3.47 g, 41%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.37 (s, 1H), 7.42−7.25 (m, 10H), 4.14−4.09 (m, 1H), 3.54−3.30 (m, 3H), 2.67 (s, 2H), 2.38−2.24 (m, 2H), and 1.97−1.85 (m, 2H). ES-LCMS <i>m</i>/<i>z</i> 308 (M + H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound <b>60</b>, <i>exo</i>-2-Methyl-1-(8-{2-[4-phenyl-1-(phenylcarbonyl)-4-piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-1<i>H</i>-benzimidazole</h3><div class="NLM_p last">Obtained analogously to <b>68</b>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.80 (m, 1H), 7.62−7.17 (m, 13H), 4.74 (m, 1H), 4.30−4.13 (m, 1H), 4.02 (m, 2H), 3.71−3.55 (m, 1H), 3.32 (s, 2H), 2.84−2.71 (m, 4H), 2.65 (s, 3H), 2.45 (m, 1H), 2.29−1.81 (m, 11H). HRMS (M + H) calcd, 533.3280; found, 533.3267.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Compound <b>62</b>, <i>exo</i>-1-(8-{2-[1-(Cyclopentylcarbonyl)-4-phenyl-4-piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3><div class="NLM_p last">Obtained analogously to <b>60</b>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.65 (m, 1H), 7.48−7.32 (m, 5H), 7.26−7.06 (m, 3H), 4.65 (m, 1H), 4.04−3.71 (m, 4H), 3.20 (m, 1H), 3.09−2.94 (m, 2H), 2.71−2.46 (m, 7H), 2.32−2.16 (m, 2H), 2.10−1.86 (m, 8H), 1.83−1.47 (m, 10H). HR MS (M + H) calcd, 525.3593; found, 525.3595.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Compound <b>63</b>, <i>endo</i>-1-(8-{2-[4-(3,4-Dichlorophenyl)-1-(phenylcarbonyl)-4-piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3><div class="NLM_p last">Compound <b>63</b> was prepared according to procedures applied toward <b>68</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.66 (d, 1H, <i>J</i> = 7.2 Hz), 7.44 (app t) overlapping 7.39 (br s, 7H total), 7.32−7.25 (m) overlapping 7.26 (s, CHCl<sub>3</sub>, 2H total), 7.18−7.14 (m, 2H), 4.60 (app quint, 1H, <i>J</i> = 8.8 Hz), 4.13 (br s, 1H), 3.57, 3.40, 3.27 (three overlapping br s, 6H total), 2.55 (s, 3H), 2.44−2.34 (m, 2H), 2.21−1.66 (m, 13H). FAB HRMS (calcd for MH<sup>+</sup>, C<sub>35</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>4</sub>O) 601.2501; found 601.2501.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Compound <b>66</b>, <i>endo</i>-1-(8-{2-[4-(3,4-Dichlorophenyl)-1-(2,2-dimethylpropanoyl)-4-piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1<i>H</i>-benzimidazole</h3><div class="NLM_p last">Prepared according to procedures used for <b>68</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.66 (d, 1H, <i>J</i> = 6.9 Hz), 7.45 (d, 1H, <i>J</i> = 8.3 Hz), 7.39 (br. s, 1H), 7.32−7.27 (m, 1H), 7.20−7.14 (br. m, 3H), 4.62 (app quint, 1H, <i>J</i> = 9.2 Hz), 3.97−3.87 (m, 2H), 3.41−3.25 (m, 4H), 2.58 (s, 3H), 2.44−2.34 (m, 2H), 2.16−2.10 (m, 2H), 1.97−1.65 (m, 12H), 1.27 (s, 9H). LRMS (ES, +ve ion) <i>m</i>/<i>z</i> 581.0 (M<sup>+</sup>), 583.3 (M + 2,<sup>37Cl</sup>).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> The Synthesis of C3-linker Analogues <b>53</b> and <b>55</b></h3><div class="NLM_p">1-Boc-4-formyl-4-phenyl-1-piperidine was obtained as described in steps a and b in procedure leading to <b>36</b>.</div><div class="NLM_p">Intermediate <b>47</b> was synthesized by adding trimethyl phosphonoacetate (4.28 mL, 26.45 mmol) dropwise to a suspension of NaH (1.15 g, 60% in mineral oil, 28.86 mmol) in toluene (100 mL) at 0 °C, stirring at rt for 1 h, followed by addition of 6.95 g (24.05 mmol) off 1-Boc-4-formyl-4-phenyl-1-piperidine in 50 mL toluene and stirring the mixture stirred at rt overnight. Following aqueous workup, solvent were removed, and the desired product was obtained as a colorless oil (8.26 g). Residue was dissolved in MeOH (200 mL), Pd/C (1 g, 5%) was added and stirred under 1 atm H<sub>2</sub> for 2.5 h, filtered through celite, and purified, resulting in 6.5 g of <b>47</b> (78% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.47−7.18 (5H, m), 3.70−3.64 (2H, m), 3.54 (3H, s), 3.12 (2H, m), 2.16−2.12 (2H, m), 1.98−1.87 (4H, m), 1.71−1.64 (2H, m), 1.43 (9H, s). LRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>29</sub>NO<sub>4</sub>, 347.2; found, 347.3 (M<sup>+</sup>).</div><div class="NLM_p last">DIBAL (38 mL, 1 M in toluene, 38 mmol) was cooled to −78 °C and added into a solution of <b>47</b> (6.5 g, 18.73 mmol) in toluene (80 mL) cooled to −78 °C. The reaction was carried out at −78 °C for 2.5 h, quenched with cooled MeOH (−78 °C), and after standard workup gave 5.72 g of <b>49</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.53 (1H, s), 7.46−7.25 (5H, m), 3.73−3.67 (2H, m), 3.10−3.05 (2H, m), 2.17−2.09 (4H, m), 1.90−1.86 (2H, t, <i>J</i> = 8.0 Hz), 1.71−1.64 (2H, m), 1.43 (9H, s). LRMS: <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>NO<sub>3</sub>, 317.2; found, 317.3 (M<sup>+</sup>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Compound <b>53</b>, 2-Methyl-1-(8-{3-[4-phenyl-1-(phenylcarbonyl)-4-piperidinyl]propyl}-8-azabicyclo[3.2.1]oct-3-yl)-1<i>H</i>-benzimidazole</h3><div class="NLM_p last">Obtained from <b>49</b> and <b>45</b> as described for <b>64</b>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.80 (m, 1H), 7.62−7.17 (m, 13H), 4.74 (m, 1H), 4.30−4.13 (m, 1H), 4.02 (m, 2H), 3.71−3.55 (m, 1H), 3.32 (s, 2H), 2.84−2.71 (m, 4H), 2.65 (s, 3H), 2.45 (m, 1H), 2.29−1.81 (m, 11H). HRMS (M + H) calcd, 533.3280; found, 533.3267.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Compound <b>55</b>, <i>tert</i>-Butyl-4-{3-[4-(2-oxo-2,3-dihydro-1<i>H</i>-benzimidazol-1-yl)piperidin-1-yl]propyl}-4-phenylpiperidine-1-carboxylate</h3><div class="NLM_p last">Obtained from <b>49</b> and 1-(4-piperidinyl)-1,3-dihydro-2<i>H</i>-benzimidazol-2-one as described for <b>69</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.43 (m, 1H), 7.32−6.98 (m, 10H), 4.28 (m, 1H), 3.65 (m, 2H), 3.09 (m, 2H), 2.87−2.84 (m, 2H), 2.37 (m, 2H), 2.18 (m, 4H), 1.95 (m, 1H), 1.70 (m, 4H), 1.54 (m, 2H), 1.41 (s, 9H), 1.14−1.00 (m, 2H). MS (electrospray +) 519.27 (M + 1).</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wieslaw M. Kazmierski</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dcabb5b9afb0bdabf2b1f2b7bda6b1b5b9aeafb7b59cbbafb7f2bfb3b1"><span class="__cf_email__" data-cfemail="a3d4cac6d0cfc2d48dce8dc8c2d9cecac6d1d0c8cae3c4d0c88dc0ccce">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Aquino</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian A. Chauder</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Deanda</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Ferris</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah K. Jones-Hertzog</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrence Kenakin</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cecilia S. Koble</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Watson</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pat Wheelan</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanbiao Yang</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Youngman</span> - <span class="hlFld-Affiliation affiliation">Infectious Diseases Center for Excellence in Drug Discovery, Molecular Discovery Research, Computational & Structural Chemistry, Drug Discovery IT, ID DMPK, Metabolic Pathways Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm800598a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazareno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strizki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, R.</span><span> </span><span class="NLM_article-title">Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[4-{2-methoxy-1(<i>R</i>)-4-(trifluoromethyl)phenyl}ethyl-3(<i>S</i>)-methyl-1-piperazinyl]-4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">2405</span> <span class="NLM_lpage">2408</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0304515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2405-2408&author=J.+R.+Tagatauthor=S.+W.+McCombieauthor=D.+Nazarenoauthor=M.+A.+Labroliauthor=Y.+Xiaoauthor=R.+W.+Steensmaauthor=J.+M.+Strizkiauthor=B.+M.+Baroudyauthor=K.+Coxauthor=J.+Lachowiczauthor=G.+Vartyauthor=R.+Watkins&title=Piperazine-Based+CCR5+Antagonists+as+HIV-1+Inhibitors.+IV.+Discovery+of+1-%5B%284%2C6-Dimethyl-5-pyrimidinyl%29carbonyl%5D-4-%5B4-%7B2-methoxy-1%28R%29-4-%28trifluoromethyl%29phenyl%7Dethyl-3%28S%29-methyl-1-piperazinyl%5D-4-methylpiperidine+%28Sch-417690%2FSch-D%29%2C+a+Potent%2C+Highly+Selective%2C+and+Orally+Bioavailable+CCR5+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm0304515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0304515%26sid%3Dliteratum%253Aachs%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DMcCombie%26aufirst%3DS.%2BW.%26aulast%3DNazareno%26aufirst%3DD.%26aulast%3DLabroli%26aufirst%3DM.%2BA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSteensma%26aufirst%3DR.%2BW.%26aulast%3DStrizki%26aufirst%3DJ.%2BM.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DWatkins%26aufirst%3DR.%26atitle%3DPiperazine-Based%2520CCR5%2520Antagonists%2520as%2520HIV-1%2520Inhibitors.%2520IV.%2520Discovery%2520of%25201-%255B%25284%252C6-Dimethyl-5-pyrimidinyl%2529carbonyl%255D-4-%255B4-%257B2-methoxy-1%2528R%2529-4-%2528trifluoromethyl%2529phenyl%257Dethyl-3%2528S%2529-methyl-1-piperazinyl%255D-4-methylpiperidine%2520%2528Sch-417690%252FSch-D%2529%252C%2520a%2520Potent%252C%2520Highly%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520CCR5%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2405%26epage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aramaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuze, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, M.</span><span> </span><span class="NLM_article-title">Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">2037</span> <span class="NLM_lpage">2048</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509703" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2037-2048&author=M.+Setoauthor=K.+Aikawaauthor=N.+Miyamotoauthor=Y.+Aramakiauthor=N.+Kanzakiauthor=K.+Takashimaauthor=Y.+Kuzeauthor=Y.+Iizawaauthor=M.+Babaauthor=M.+Shiraishi&title=Highly+Potent+and+Orally+Active+CCR5+Antagonists+as+Anti-HIV-1+Agents%3A+Synthesis+and+Biological+Activities+of+1-Benzazocine+Derivatives+Containing+a+Sulfoxide+Moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety</span></div><div class="casAuthors">Seto, Masaki; Aikawa, Katsuji; Miyamoto, Naoki; Aramaki, Yoshio; Kanzaki, Naoyuki; Takashima, Katsunori; Kuze, Yoji; Iizawa, Yuji; Baba, Masanori; Shiraishi, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. modification was performed on the orally bioavailable and potent CCR5 antagonist sulfoxide compd. I, mainly focusing on replacement of the [6,7]-fused 1-benzazepine nucleus.  Ring-expanded [6,8]-, [6,9]-, and [6,10]-fused compds. contg. S-sulfoxide moieties were prepd. and evaluated for biol. activities which led to 1-benzazocine and 1-benzazonine compds. that exhibited potent inhibitory activities.  1-Benzazocine compds. possessing the S-sulfoxide moiety showed greater potency than I in a fusion assay.  Further investigation in a multi-round infection assay showed that the 1-isobutyl-1-benzazocine compd. II, contg. the S-[[(1-propyl-1H-imidazol)-5-yl]methyl]sulfinyl group, showed the most potent anti-HIV-1 activity.  II (TAK-652) also inhibited the replication of six macrophage-tropic HIV-1 clin. isolates in peripheral blood mononuclear cells.  It was also absorbed after oral administration in rats, dogs, and monkeys and was thus selected as a clin. candidate.  The synthesis and biol. activity of II and derivs. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6VVfNAhytC7Vg90H21EOLACvtfcHk0liD_N1qcXyWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVCjsrY%253D&md5=e579dea40031ca3ac3d7b2d96875ab4c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm0509703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509703%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DAramaki%26aufirst%3DY.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DKuze%26aufirst%3DY.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DShiraishi%26aufirst%3DM.%26atitle%3DHighly%2520Potent%2520and%2520Orally%2520Active%2520CCR5%2520Antagonists%2520as%2520Anti-HIV-1%2520Agents%253A%2520Synthesis%2520and%2520Biological%2520Activities%2520of%25201-Benzazocine%2520Derivatives%2520Containing%2520a%2520Sulfoxide%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2037%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span> </span><span class="NLM_article-title">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=15850827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=239-271&author=A.+Woodauthor=D.+Armour&title=The+discovery+of+the+CCR5+receptor+antagonist%2C+UK-427%2C857%2C+a+new+agent+for+the+treatment+of+HIV+infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span></div><div class="casAuthors">Wood, Anthony; Armour, Duncan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-271</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The drug discovery program that led to the identification of UK-427,857, a prototype CCR5 antagonist with excellent potency against lab-adapted and primary HIV-1 isolates, as a clin. candidate for the treatment of HIV is described.  In particular, strategies for minimizing cardiac toxicity while maintaining ADME properties commensurate with low dose are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJQwMygW-grVg90H21EOLACvtfcHk0liD_N1qcXyWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D&md5=8c4bb50b02b7e6d8cfa13d844e39017c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26aulast%3DArmour%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">CCR5 chemokine receptors: gatekeepers of HIV-1 infection</span> <span class="citation_source-journal">Curr. Drug Targets: Inf. Disord.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">265</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.2174%2F1568005023342489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=12462129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsV2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=265-278&author=W.+M.+Kazmierskiauthor=L.+Booneauthor=W.+Lawrenceauthor=C.+Watsonauthor=T.+Kenakin&title=CCR5+chemokine+receptors%3A+gatekeepers+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">CCR5 chemokine receptors: gatekeepers of HIV-1 infection</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Boone, Larry; Lawrence, Wendell; Watson, Chris; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-278</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  With the discovery that CCR5 is the crit. protein required for infection by M-tropic HIV, have come huge research efforts, both in academia and industry, to try to exploit this finding.  Thus, research advances in the fields of virol., structural protein chem., and receptor pharmacol. have combined to add a new understanding to the process of HIV fusion and possible mechanisms to prevent HIV entry.  This review will approach this field from a receptor pharmacol. viewpoint and outline some concepts of receptor allosterism and protein-protein interaction which may be relevant to CCR5 blockade.  Many of these ideas may be explored in a practical sense with the advent of new small mol. CCR5 inhibitors currently entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGnKY0SACfMrVg90H21EOLACvtfcHk0ljj8Fd6pqWaTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsV2htLw%253D&md5=494c7dfa285e6431b8e4f75d2b14f260</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1568005023342489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005023342489%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DCCR5%2520chemokine%2520receptors%253A%2520gatekeepers%2520of%2520HIV-1%2520infection%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Inf.%2520Disord.%26date%3D2002%26volume%3D2%26spage%3D265%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAnda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">2663</span> <span class="NLM_lpage">2676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2663-2676&author=W.+Kazmierskiauthor=N.+Bifulcoauthor=H.+Yangauthor=L.+Booneauthor=F.+DeAndaauthor=C.+Watsonauthor=T.+Kenakin&title=Recent+progress+in+discovery+of+small-molecule+CCR5+chemokine+receptor+ligands+as+HIV-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DBifulco%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DDeAnda%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DRecent%2520progress%2520in%2520discovery%2520of%2520small-molecule%2520CCR5%2520chemokine%2520receptor%2520ligands%2520as%2520HIV-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2663%26epage%3D2676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAnda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors. [Erratum to document cited in CA139:332100]</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">4155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4155&author=W.+Kazmierskiauthor=N.+Bifulcoauthor=H.+Yangauthor=L.+Booneauthor=F.+DeAndaauthor=C.+Watsonauthor=T.+Kenakin&title=Recent+progress+in+discovery+of+small-molecule+CCR5+chemokine+receptor+ligands+as+HIV-1+inhibitors.+%5BErratum+to+document+cited+in+CA139%3A332100%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DBifulco%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DDeAnda%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DRecent%2520progress%2520in%2520discovery%2520of%2520small-molecule%2520CCR5%2520chemokine%2520receptor%2520ligands%2520as%2520HIV-1%2520inhibitors.%2520%255BErratum%2520to%2520document%2520cited%2520in%2520CA139%253A332100%255D%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span> </span><span class="NLM_article-title">Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">13</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1111%2Fj.1747-0285.2005.00319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=16492145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=13-26&author=W.+M.+Kazmierskiauthor=T.+P.+Kenakinauthor=K.+S.+Gudmundsson&title=Peptide%2C+peptidomimetic+and+small-molecule+drug+discovery+targeting+HIV-1+host-cell+attachment+and+entry+through+gp120%2C+gp41%2C+CCR5+and+CXCR4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Kenakin, Terry P.; Gudmundsson, Kristjan S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  This review highlights selected examples of peptide, peptidomimetic and small-mol. drug discovery targeting HIV-1 to advance novel anti-HIV pharmaceuticals that inhibit initial stages of the viral cycle; namely, attachment and entry.  Some of these approaches have culminated in the development of peptide-based drugs, while other have exploited peptides as enabling tools toward the identification of small-mol. lead compds.  Both of these conceptually different approaches have facilitated lead optimization of mols. with complementary and often surprising anti-HIV pharmacol. properties, supporting their role in pharmaceutical development.  Furthermore, such mols. enabled mechanistic elucidation of viral attachment and entry and provided addnl. insights toward achieving the desired drug profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nkSa0geKc7Vg90H21EOLACvtfcHk0lgH-OfmSsbrXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7s%253D&md5=78456a867f86f18501f3f02009444a8c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00319.x%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26atitle%3DPeptide%252C%2520peptidomimetic%2520and%2520small-molecule%2520drug%2520discovery%2520targeting%2520HIV-1%2520host-cell%2520attachment%2520and%2520entry%2520through%2520gp120%252C%2520gp41%252C%2520CCR5%2520and%2520CXCR4%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, P. L.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of new CCR5 and CXCR4 chemokine receptor antagonists as inhibitors of HIV-1 entry. Part 2</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infective Agents</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.2174%2F1568012053506981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=133-152&author=W.+M.+Kazmierskiauthor=J.+P.+Peckhamauthor=M.+Duanauthor=T.+P.+Kenakinauthor=S.+Jenkinsonauthor=K.+S.+Gudmundssonauthor=S.+C.+Piscitelliauthor=P.+L.+Feldman&title=Recent+progress+in+the+discovery+of+new+CCR5+and+CXCR4+chemokine+receptor+antagonists+as+inhibitors+of+HIV-1+entry.+Part+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of new CCR5 and CXCR4 chemokine receptor antagonists as inhibitors of HIV-1 entry. Part 2</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Peckham, Jennifer P.; Duan, Maosheng; Kenakin, Terry P.; Jenkinson, Stephen; Gudmundsson, Kristjan S.; Piscitelli, Stephen C.; Feldman, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review addresses key medicinal chem. issues relevant in the discovery and development of CCR5 and CXCR4 antagonists as anti-HIV drugs.  Recent progress in the discovery and development of such antagonists, SAR and clin. status are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6-6WXVA7DY7Vg90H21EOLACvtfcHk0lgH-OfmSsbrXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtrs%253D&md5=a0076b06de22e5bc4c2ce5ad5a4ad74c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568012053506981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012053506981%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520new%2520CCR5%2520and%2520CXCR4%2520chemokine%2520receptor%2520antagonists%2520as%2520inhibitors%2520of%2520HIV-1%2520entry.%2520Part%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infective%2520Agents%26date%3D2005%26volume%3D4%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span> </span><span class="NLM_article-title">Small molecule CCR5 and CXCR4-based viral entry inhibitors for anti-HIV therapy currently in development</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">301</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=301-320&author=W.+M.+Kazmierskiauthor=K.+S.+Gudmundssonauthor=S.+C.+Piscitelli&title=Small+molecule+CCR5+and+CXCR4-based+viral+entry+inhibitors+for+anti-HIV+therapy+currently+in+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26atitle%3DSmall%2520molecule%2520CCR5%2520and%2520CXCR4-based%2520viral%2520entry%2520inhibitors%2520for%2520anti-HIV%2520therapy%2520currently%2520in%2520development%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D301%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tsibris, A. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuritzkes, D. R.</span><span> </span><span class="NLM_article-title">Chemokine antagonists as therapeutics: focus on HIV-1</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">445</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2007&pages=445-459&author=A.+M.+N.+Tsibrisauthor=D.+R.+Kuritzkes&title=Chemokine+antagonists+as+therapeutics%3A+focus+on+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsibris%26aufirst%3DA.%2BM.%2BN.%26aulast%3DKuritzkes%26aufirst%3DD.%2BR.%26atitle%3DChemokine%2520antagonists%2520as%2520therapeutics%253A%2520focus%2520on%2520HIV-1%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2007%26volume%3D58%26spage%3D445%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span> </span><span class="NLM_article-title">Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">2851</span> <span class="NLM_lpage">2857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060009x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2851-2857&author=A.+Palaniauthor=J.+R.+Tagat&title=Discovery+and+Development+of+Small-Molecule+Chemokine+Coreceptor+CCR5+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists</span></div><div class="casAuthors">Palani, Anandan; Tagat, Jayaram R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2851-2857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the discovery and development of small-mol. chemokine coreceptor CCR5 antagonists for treatment of HIV infections and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNiMYyMzPNn7Vg90H21EOLACvtfcHk0liby4OzVNwViQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslKlu7k%253D&md5=bdbc44ab09ac0fedc6b270fba34f4ce0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060009x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060009x%26sid%3Dliteratum%253Aachs%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Small-Molecule%2520Chemokine%2520Coreceptor%2520CCR5%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2851%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span> </span><span class="NLM_article-title">CCR5 antagonists: Host-targeted antivirals for the treatment of HIV infection</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">339</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=339-354&author=M.+Westbyauthor=E.+van+der+Ryst&title=CCR5+antagonists%3A+Host-targeted+antivirals+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestby%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26atitle%3DCCR5%2520antagonists%253A%2520Host-targeted%2520antivirals%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2005%26volume%3D16%26spage%3D339%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Barnum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smellie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprague, P.</span><span> </span><span class="NLM_article-title">Identification of Common Functional Configurations Among Molecules</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">563</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci950273r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADyaK28Xis1yjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1996&pages=563-571&author=D.+Barnumauthor=J.+Greeneauthor=A.+Smellieauthor=P.+Sprague&title=Identification+of+Common+Functional+Configurations+Among+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Common Functional Configurations Among Molecules</span></div><div class="casAuthors">Barnum, Doug; Greene, Jonathan; Smellie, Andrew; Sprague, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-71</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new algorithm for identifying three-dimensional configurations of chem. features common to a set of mols. is described.  The algorithm scores each configuration based both on the degree to which it is common to the input set and its estd. rarity.  The algorithm can be applied to mols. with large (several hundred) conformational models.  Results from the application of this algorithm to three data sets are discussed: PAF antagonists, HIV reverse transcriptase inhibitors, and HIV protease inhibitors.  Of particular interest is a common configuration identified for a set of HIV reverse transcriptase inhibitors; this configuration is shared by two new, potent inhibitors that were recently described in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq51RMW7hGC_LVg90H21EOLACvtfcHk0ljjmedW1Mbg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1yjsLw%253D&md5=39566bdbd6895c8b76145ba25471abf2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fci950273r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci950273r%26sid%3Dliteratum%253Aachs%26aulast%3DBarnum%26aufirst%3DD.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DSmellie%26aufirst%3DA.%26aulast%3DSprague%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520Common%2520Functional%2520Configurations%2520Among%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1996%26volume%3D36%26spage%3D563%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">1268</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1124%2Fmol.104.008565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=15644495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=1268-1282&author=C.+Watsonauthor=S.+Jenkinsonauthor=W.+Kazmierskiauthor=T.+Kenakin&title=The+CCR5+receptor-based+mechanism+of+action+of+873140%2C+a+potent+allosteric+noncompetitive+HIV+entry+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor</span></div><div class="casAuthors">Watson, Christian; Jenkinson, Stephen; Kazmierski, Wieslaw; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1268-1282</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">4-{[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenyl]oxy}benzoic acid hydrochloride (873140) is a potent noncompetitive allosteric antagonist of the CCR5 receptor (pKB = 8.6±0.07; 95% Cl, 8.5 to 8.8) with concomitantly potent antiviral effects for HIV-1.  In this article, the receptor-based mechanism of action of 873140 is compared with four other noncompetitive allosteric antagonists of CCR5.  Although (Z)-(4-bromophenyl){1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1,4'-bipiperidin-4-yl}methanone O-ethyloxime (Sch-C; SCH 351125), 4,6-dimethyl-5-{[4-methyl-4-((3S)-3-methyl-4-{(1R)-2-(methyloxy)-1-[4-(trifluoromethyl)phenyl]ethyl}-1-piperazinyl)-1-piperidinyl]carbonyl}pyrimidine (Sch-D; SCH 417,690), 4,4-difluoro-N-((1S)-3-{(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenyl-propyl)cyclohexanecarboxamide (UK-427,857), and N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclo-hepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride (TAK779) blocked the binding of both chemokines 125I-MIP-1α (also known as 125I-CCL3, 125I-LD78) and 125I-RANTES (125I-CCL5), 873140 was an ineffectual antagonist of 125I-RANTES (regulated on activation normal T cell expressed and secreted) binding (but did block binding of 125I-MIP-1α).  Furthermore, 873140 blocked the calcium response effects of CCR5 activation by CCL5 (RANTES) (as did the other antagonists), indicating a unique divergence of blockade of function and binding with this antagonist.  The antagonism of CCR5 by 873140 is saturable and probe-dependent, consistent with an allosteric mechanism of action.  The blockade of CCR5 by 873140 was extremely persistent with a rate const. for reversal of <0.004 h-1 (t1/2 > 136 h).  Coadministration studies of 873140 with the four other allosteric antagonists yielded data that are consistent with the notion that all five of these antagonists bind to a common allosteric site on the CCR5 receptor.  Although these ligands may have a common binding site, they do not exert the same allosteric effect on the receptor, as indicated by their differential effects on the binding of 125I-RANTES.  This idea is discussed in terms of using these drugs sequentially to overcome HIV viral resistance in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQkUJlzWK3HbVg90H21EOLACvtfcHk0ljjmedW1Mbg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFWmsLg%253D&md5=576b260ae1c12d5291451a8dadc6c0af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.008565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.008565%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DThe%2520CCR5%2520receptor-based%2520mechanism%2520of%2520action%2520of%2520873140%252C%2520a%2520potent%2520allosteric%2520noncompetitive%2520HIV%2520entry%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D1268%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pearlman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. M.</span><span> </span><span class="NLM_article-title">Novel software tools for chemical diversity</span> <span class="citation_source-journal">Persp. Drug Discovery Des.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">339</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1023%2FA%3A1027232610247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADyaK1cXksVantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=339-353&author=R.+S.+Pearlmanauthor=K.+M.+Smith&title=Novel+software+tools+for+chemical+diversity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel software tools for chemical diversity</span></div><div class="casAuthors">Pearlman, Robert S.; Smith, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9/10/11</span>
        (<span class="NLM_cas:issue">3D QSAR in Drug Design: Ligand/Protein Interactions and Molecular Similarity</span>),
    <span class="NLM_cas:pages">339-353</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 24 refs. is given including chem.-space concepts and diversity-related algorithms, BCUT (Burden, Chem. Abstr. Service, University of Texas) values, validation of chem.-space metrics, using low-dimensional metrics for diversity-related tasks, simple and biased diverse subset selection, identifying and filling in diversity voids, and comparing the diversities of 2 or more populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY_gw_7KVrArVg90H21EOLACvtfcHk0ljjmedW1Mbg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVantLc%253D&md5=66a1de522730ef3b1c1d80d95c3e669a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1023%2FA%3A1027232610247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1027232610247%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26atitle%3DNovel%2520software%2520tools%2520for%2520chemical%2520diversity%26jtitle%3DPersp.%2520Drug%2520Discovery%2520Des.%26date%3D1998%26volume%3D9%26spage%3D339%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kazmierski, W.; Anderson, D. L.; Aquino, C. J.; Bifulco, N.; Boone, L. R.; Boros, E. E.; Chauder, B. A.; Chong, P. Y.; Duan, M.; Ferris, R. G.; Kenakin, T. P.; Koble, C. S.; Lang, D. G.; McLean, E.; McIntyre, M. S.; Peckham, J. P.; Spaltenstein, A.; Svolto, A. C.; Thompson, J. B.; Yang, H.; Youngman, M. K.; Wheelan, P. J.</span><span> </span><span class="NLM_article-title">Novel, potent and bioavailable CCR5 chemokine receptor small-molecule antagonists for HIV therapy: scaffold discovery and addressing hERG ion channel affinity in the process of optimizing potency and bioavailability</span>. <span class="NLM_conf-name">232nd ACS National Meeting</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sept. 10−14, 2006</span>, <span class="NLM_elocation-id">MEDI-297.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kazmierski%2C+W.%3B+Anderson%2C+D.+L.%3B+Aquino%2C+C.+J.%3B+Bifulco%2C+N.%3B+Boone%2C+L.+R.%3B+Boros%2C+E.+E.%3B+Chauder%2C+B.+A.%3B+Chong%2C+P.+Y.%3B+Duan%2C+M.%3B+Ferris%2C+R.+G.%3B+Kenakin%2C+T.+P.%3B+Koble%2C+C.+S.%3B+Lang%2C+D.+G.%3B+McLean%2C+E.%3B+McIntyre%2C+M.+S.%3B+Peckham%2C+J.+P.%3B+Spaltenstein%2C+A.%3B+Svolto%2C+A.+C.%3B+Thompson%2C+J.+B.%3B+Yang%2C+H.%3B+Youngman%2C+M.+K.%3B+Wheelan%2C+P.+J.+Novel%2C+potent+and+bioavailable+CCR5+chemokine+receptor+small-molecule+antagonists+for+HIV+therapy%3A+scaffold+discovery+and+addressing+hERG+ion+channel+affinity+in+the+process+of+optimizing+potency+and+bioavailability.+232nd+ACS+National+Meeting%2C+San+Francisco%2C+CA%2C+Sept.+10%E2%88%9214%2C+2006%2C+MEDI-297."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26atitle%3DNovel%252C%2520potent%2520and%2520bioavailable%2520CCR5%2520chemokine%2520receptor%2520small-molecule%2520antagonists%2520for%2520HIV%2520therapy%253A%2520scaffold%2520discovery%2520and%2520addressing%2520hERG%2520ion%2520channel%2520affinity%2520in%2520the%2520process%2520of%2520optimizing%2520potency%2520and%2520bioavailability" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kazmierski, W. M.; Aquino, C. J.; Bifulco, N.; Boros, E. E.; Chauder, B. A.; Chong, P. Y.; Duan, M.; Deanda, F., Jr.; Koble, C. S.; Mclean, E. W.; Peckham, J. P.; Perkins, A. C.; Thompson, J. B.; Vanderwall, D.</span><span> </span><span class="NLM_article-title">Preparation of benzimidazolylazabicyclooctylethylpiperidines as CCR5 antagonists for the treatment of HIV infection</span>. Patent WO2004054974, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+M.+Kazmierski&author=C.+J.+Aquino&author=N.+Bifulco&author=E.+E.+Boros&author=B.+A.+Chauder&author=P.+Y.+Chong&author=M.+Duan&author=F.%2C+Jr.+Deanda&author=C.+S.+Koble&author=E.+W.+Mclean&author=J.+P.+Peckham&author=A.+C.+Perkins&author=J.+B.+Thompson&author=D.+Vanderwall&title=Preparation+of+benzimidazolylazabicyclooctylethylpiperidines+as+CCR5+antagonists+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26atitle%3DPreparation%2520of%2520benzimidazolylazabicyclooctylethylpiperidines%2520as%2520CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yang, H.; Kazmierski, W. M.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolidine and azetidine compounds as CCR5 antagonists</span>. Patent WO2004055016, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+Yang&author=W.+M.+Kazmierski&author=C.+J.+Aquino&title=Preparation+of+pyrrolidine+and+azetidine+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520pyrrolidine%2520and%2520azetidine%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Duan, M.; Kazmierski, W. M.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclylalkyl substituted cyclohexyl compounds as CCR5 antagonists</span>. Patent WO2004054581, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Duan&author=W.+M.+Kazmierski&author=C.+J.+Aquino&title=Preparation+of+heterocyclylalkyl+substituted+cyclohexyl+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520heterocyclylalkyl%2520substituted%2520cyclohexyl%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Aquino, C. J.; Chong, P. Y.; Duan, M.; Kazmierski, W. M.</span><span> </span><span class="NLM_article-title">Preparation of oxazine and morpholine derivatives as CCR5 antagonists</span>. Patent WO2004055011, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+J.+Aquino&author=P.+Y.+Chong&author=M.+Duan&author=W.+M.+Kazmierski&title=Preparation+of+oxazine+and+morpholine+derivatives+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520oxazine%2520and%2520morpholine%2520derivatives%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Peckham, J. P.; Aquino, C. J.; Kazmierski, W. M.</span><span> </span><span class="NLM_article-title">Preparation of aminoalkylaryl cyclopropyl compounds as CCR5 antagonists</span>. Patent WO2004055010, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+P.+Peckham&author=C.+J.+Aquino&author=W.+M.+Kazmierski&title=Preparation+of+aminoalkylaryl+cyclopropyl+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26atitle%3DPreparation%2520of%2520aminoalkylaryl%2520cyclopropyl%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Youngman, M.; Kazmierski, W. M.; Yang, H.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of indane compounds and analogs as CCR5 antagonists</span>. Patent WO2004055012, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Youngman&author=W.+M.+Kazmierski&author=H.+Yang&author=C.+J.+Aquino&title=Preparation+of+indane+compounds+and+analogs+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520indane%2520compounds%2520and%2520analogs%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dostert, P.; Imbert, T.; Bucher, B.</span><span> </span><span class="NLM_article-title">β-3-Aminonortropane derivatives</span>. Fr. Demande Appl. No. 79 00971, <span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=P.+Dostert&author=T.+Imbert&author=B.+Bucher&title=%CE%B2-3-Aminonortropane+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DP.%26atitle%3D%25CE%25B2-3-Aminonortropane%2520derivatives%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Harrison, T.; Swain, C. J.</span><span> </span><span class="NLM_article-title">Preparation of 3,3-disubstituted piperidines for treating the conditions associated with an excess of tachykinins</span>. U.S. Patent 5807865, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+Harrison&author=C.+J.+Swain&title=Preparation+of+3%2C3-disubstituted+piperidines+for+treating+the+conditions+associated+with+an+excess+of+tachykinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DPreparation%2520of%25203%252C3-disubstituted%2520piperidines%2520for%2520treating%2520the%2520conditions%2520associated%2520with%2520an%2520excess%2520of%2520tachykinins%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grugni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigolio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassallo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, C.</span><span> </span><span class="NLM_article-title">A reliable and efficient synthesis of SR 142801</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">2307</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=2307-2310&author=G.+A.+M.+Giardinaauthor=M.+Grugniauthor=R.+Rigolioauthor=M.+Vassalloauthor=K.+Erhardauthor=C.+Farina&title=A+reliable+and+efficient+synthesis+of+SR+142801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26aulast%3DGrugni%26aufirst%3DM.%26aulast%3DRigolio%26aufirst%3DR.%26aulast%3DVassallo%26aufirst%3DM.%26aulast%3DErhard%26aufirst%3DK.%26aulast%3DFarina%26aufirst%3DC.%26atitle%3DA%2520reliable%2520and%2520efficient%2520synthesis%2520of%2520SR%2520142801%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D2307%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Emonds-Alt, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaulme, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miloux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poncelet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proietto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breliere, J. C.</span><span> </span><span class="NLM_article-title">SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">PL27</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=PL27-32&author=X.+Emonds-Altauthor=D.+Bichonauthor=J.+P.+Ducouxauthor=M.+Heaulmeauthor=B.+Milouxauthor=M.+Ponceletauthor=V.+Proiettoauthor=D.+Van+Broeckauthor=P.+Vilainauthor=G.+Neliatauthor=P.+Soubrieauthor=G.+Le+Furauthor=J.+C.+Breliere&title=SR+142801%2C+the+first+potent+non-peptide+antagonist+of+the+tachykinin+NK3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmonds-Alt%26aufirst%3DX.%26aulast%3DBichon%26aufirst%3DD.%26aulast%3DDucoux%26aufirst%3DJ.%2BP.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DMiloux%26aufirst%3DB.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DProietto%26aufirst%3DV.%26aulast%3DVan%2BBroeck%26aufirst%3DD.%26aulast%3DVilain%26aufirst%3DP.%26aulast%3DNeliat%26aufirst%3DG.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DBreliere%26aufirst%3DJ.%2BC.%26atitle%3DSR%2520142801%252C%2520the%2520first%2520potent%2520non-peptide%2520antagonist%2520of%2520the%2520tachykinin%2520NK3%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D56%26spage%3DPL27%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">3103</span> <span class="NLM_lpage">3106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=3103-3106&author=D.+Kimauthor=L.+Wangauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+E.+Finkeauthor=B.+Oatesauthor=M.+MacCossauthor=S.+G.+Millsauthor=L.+Malkowitzauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=M.+S.+Springerauthor=D.+Hazudaauthor=M.+Millerauthor=J.+Kesslerauthor=R.+Danzeisenauthor=G.+Carverauthor=A.+Carellaauthor=K.+Holmesauthor=J.+Linebergerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Design%2C+synthesis%2C+and+SAR+of+heterocycle-containing+antagonists+of+the+human+CCR5+receptor+for+the+treatment+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DOates%26aufirst%3DB.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520of%2520heterocycle-containing%2520antagonists%2520of%2520the%2520human%2520CCR5%2520receptor%2520for%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D3103%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chauder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabet, E.</span><span> </span><span class="NLM_article-title">Synthesis of 4-substituted piperidines via a mild and scalable two-step Cu2O-mediated decarboxylation of cyanoesters</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">279</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1080%2F00397910500374971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmtl2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=279-284&author=B.+Chauderauthor=E.+Borosauthor=K.+Duauthor=W.+Kazmierskiauthor=C.+Kobleauthor=J.+Thompsonauthor=E.+Tabet&title=Synthesis+of+4-substituted+piperidines+via+a+mild+and+scalable+two-step+Cu2O-mediated+decarboxylation+of+cyanoesters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-substituted piperidines via a mild and scalable two-step Cu2O-mediated decarboxylation of cyanoesters</span></div><div class="casAuthors">Chauder, Brian; Boros, Eric; Du, Kien; Kazmierski, Wieslaw; Koble, Cecilia; Thompson, James; Tabet, Elie</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A four-step, high-yielding, kilogram-scale protocol to prep. piperidyl-acetaldehyde deriv. is reported.  The key reaction is a mild, two-step Cu2O-mediated decarboxylation of piperidyl-cyanoester that proceeds in excellent yield.  The general applicability of this methodol. was also explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk6gg6XLzy7Vg90H21EOLACvtfcHk0liIGvqMMFgGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmtl2juw%253D%253D&md5=b46a6e1f9e37b814dbae34b3d73f0891</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00397910500374971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500374971%26sid%3Dliteratum%253Aachs%26aulast%3DChauder%26aufirst%3DB.%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DKoble%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DTabet%26aufirst%3DE.%26atitle%3DSynthesis%2520of%25204-substituted%2520piperidines%2520via%2520a%2520mild%2520and%2520scalable%2520two-step%2520Cu2O-mediated%2520decarboxylation%2520of%2520cyanoesters%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D279%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chauder, B. A.; Anderson, D.; Aquino, C. J.; Bifulco, N.; Boone, L. R.; Boros, E. E.; Chong, P. Y.; Du, K. S.; Duan, M.; Ferris, R. G.; Kazmierski, W. M.; Kenakin, T. P.; Koble, C. S.; Lang, D. G.; Peckham, J. P.; Spaltenstein, A.; Thompson, J. B.; Youngman, M. K.; Wheelan, P. J.</span><span> </span><span class="NLM_article-title">Discovery and design of potent piperidine-based CCR5 antagonists for the potential treatment of HIV-1 infection</span>. <span class="NLM_conf-name">232nd ACS National Meeting</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sept. 10−14, 2006</span>,  <span class="NLM_fpage">MEDI-242</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chauder%2C+B.+A.%3B+Anderson%2C+D.%3B+Aquino%2C+C.+J.%3B+Bifulco%2C+N.%3B+Boone%2C+L.+R.%3B+Boros%2C+E.+E.%3B+Chong%2C+P.+Y.%3B+Du%2C+K.+S.%3B+Duan%2C+M.%3B+Ferris%2C+R.+G.%3B+Kazmierski%2C+W.+M.%3B+Kenakin%2C+T.+P.%3B+Koble%2C+C.+S.%3B+Lang%2C+D.+G.%3B+Peckham%2C+J.+P.%3B+Spaltenstein%2C+A.%3B+Thompson%2C+J.+B.%3B+Youngman%2C+M.+K.%3B+Wheelan%2C+P.+J.+Discovery+and+design+of+potent+piperidine-based+CCR5+antagonists+for+the+potential+treatment+of+HIV-1+infection.+232nd+ACS+National+Meeting%2C+San+Francisco%2C+CA%2C+Sept.+10%E2%88%9214%2C+2006%2C+MEDI-242."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChauder%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520and%2520design%2520of%2520potent%2520piperidine-based%2520CCR5%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520HIV-1%2520infection%26spage%3DMEDI-242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span> </span><span class="NLM_article-title">Development of a High-Throughput Viral-Free Assay for the Measurement of CCR5-Mediated HIV/Cell Fusion</span> <span class="citation_source-journal">Recept.Channels</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">117</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1080%2F10606820308248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=12916472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVGjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=117-123&author=S.+Jenkinsonauthor=D.+McCoyauthor=S.+Kernerauthor=R.+Ferrisauthor=W.+Lawrenceauthor=T.+Foxauthor=C.+Smith&title=Development+of+a+High-Throughput+Viral-Free+Assay+for+the+Measurement+of+CCR5-Mediated+HIV%2FCell+Fusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a High-Throughput Viral-Free Assay for the Measurement of CCR5-Mediated HIV/Cell Fusion</span></div><div class="casAuthors">Jenkinson, Stephen; McCoy, David; Kerner, Sandy; Ferris, Rob; Lawrence, Wendell; Fox, Tony; Smith, Chari</div><div class="citationInfo"><span class="NLM_cas:title">Receptors and Channels</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">RCHAE4</span>;
        ISSN:<span class="NLM_cas:issn">1060-6823</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">M-tropic HIV strains gain access to their host cell via interaction of the viral envelope protein gp120 with the CCR5 coreceptor and CD4 located on the host cell.  Inhibition of this event has been shown to reduce viral fusion and entry into cells in vitro.  In the present study we describe the development of a novel cell/cell fusion assay that both mimics the viral/cell fusion process and allows quantification of this event.  The assay has been characterized both biochem., using selective antibodies, and pharmacol., using selective CCR5 antagonists, and has been shown to be selective for examg. the interaction of viral gp120 with hCCR5/hCD4.  In addn., compd. pIC50 data obtained from this cell/cell fusion assay correlates well (r2 = 0.7274) with data obtained from an HIV-1 replication assay.  Furthermore, this assay has the added ability to simultaneously det. compd. toxicity, thus allowing rapid detn. of active, non-toxic compds.  In conclusion, the cell/cell fusion assay developed has been demonstrated to be a suitable surrogate assay that can be used to assess the effects of compds. on gp120/CCR5/CD4 mediated viral fusion into host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEqHHnl0c5bVg90H21EOLACvtfcHk0liIGvqMMFgGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVGjurw%253D&md5=a0e53f50eb24a2c4c44d35ff7e16e5ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F10606820308248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10606820308248%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DMcCoy%26aufirst%3DD.%26aulast%3DKerner%26aufirst%3DS.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DFox%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520High-Throughput%2520Viral-Free%2520Assay%2520for%2520the%2520Measurement%2520of%2520CCR5-Mediated%2520HIV%252FCell%2520Fusion%26jtitle%3DRecept.Channels%26date%3D2003%26volume%3D9%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">3147</span> <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1128%2FAAC.00401-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=17620375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVais73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3147-3154&author=R.+Hazenauthor=R.+Harveyauthor=R.+Ferrisauthor=C.+Craigauthor=P.+Yatesauthor=P.+Griffinauthor=J.+Millerauthor=I.+Kaldorauthor=J.+Rayauthor=V.+Samanoauthor=E.+Furfineauthor=A.+Spaltensteinauthor=M.+Haleauthor=R.+Tungauthor=M.+St.+Clairauthor=M.+Hanlonauthor=L.+Boone&title=In+vitro+antiviral+activity+of+the+novel%2C+tyrosyl-based+human+immunodeficiency+virus+%28HIV%29+type+1+protease+inhibitor+brecanavir+%28GW640385%29+in+combination+with+other+antiretrovirals+and+against+a+panel+of+protease+inhibitor-resistant+HIV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV</span></div><div class="casAuthors">Hazen, Richard; Harvey, Robert; Ferris, Robert; Craig, Charles; Yates, Phillip; Griffin, Philip; Miller, John; Kaldor, Istvan; Ray, John; Samano, Vincente; Furfine, Eric; Spaltenstein, Andrew; Hale, Michael; Tung, Roger; St. Clair, Marty; Hanlon, Mary; Boone, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-3154</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brecanavir, a novel tyrosyl-based arylsulfonamide, high-affinity, human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI), has been evaluated for anti-HIV activity in several in vitro assays.  Preclin. assessment of brecanavir indicated that this compd. potently inhibited HIV-1 in cell culture assays with 50% effective concns. (EC50s) of 0.2 to 0.53 nM and was equally active against HIV strains utilizing either the CXCR4 or CCR5 coreceptor, as was found with other PIs.  The presence of up to 40% human serum decreased the anti-HIV-1 activity of brecanavir by 5.2-fold, but under these conditions the compd. retained single-digit nanomolar EC50s.  When brecanavir was tested in combination with nucleoside reverse transcriptase inhibitors, the antiviral activity of brecanavir was synergistic with the effects of stavudine and additive to the effects of zidovudine, tenofovir, dideoxycytidine, didanosine, adefovir, abacavir, lamivudine, and emtricitabine.  Brecanavir was synergistic with the nonnucleoside reverse transcriptase inhibitor nevirapine or delavirdine and was additive to the effects of efavirenz.  In combination with other PIs, brecanavir was additive to the activities of indinavir, lopinavir, nelfinavir, ritonavir, amprenavir, saquinavir, and atazanavir.  Clin. HIV isolates from PI-experienced patients were evaluated for sensitivity to brecanavir and other PIs in a recombinant virus assay.  Brecanavir had a <5-fold increase in EC50s against 80% of patient isolates tested and had a greater mean in vitro potency than amprenavir, indinavir, lopinavir, atazanavir, tipranavir, and darunavir.  Brecanavir is by a substantial margin the most potent and broadly active antiviral agent among the PIs tested in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplFzzXvQJ9rVg90H21EOLACvtfcHk0lh84jxERnZQAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVais73F&md5=a84fb4b36143fb6c9e92db4895ad1d9d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.00401-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00401-07%26sid%3Dliteratum%253Aachs%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DR.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DI.%26aulast%3DRay%26aufirst%3DJ.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DFurfine%26aufirst%3DE.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DHale%26aufirst%3DM.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DSt.%2BClair%26aufirst%3DM.%26aulast%3DHanlon%26aufirst%3DM.%26aulast%3DBoone%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520of%2520the%2520novel%252C%2520tyrosyl-based%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520type%25201%2520protease%2520inhibitor%2520brecanavir%2520%2528GW640385%2529%2520in%2520combination%2520with%2520other%2520antiretrovirals%2520and%2520against%2520a%2520panel%2520of%2520protease%2520inhibitor-resistant%2520HIV%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3147%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mariam A. El-Zohairy, Darius P. Zlotos, Martin R. Berger, Hassan H. Adwan, <span class="NLM_string-name hlFld-ContribAuthor">Yasmine M. Mandour</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (16)
                                     , 10921-10935. <a href="https://doi.org/10.1021/acsomega.1c00681" title="DOI URL">https://doi.org/10.1021/acsomega.1c00681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00681%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BNovel%252BCCR5%252BLigands%252Bas%252BAnticolorectal%252BCancer%252BAgents%252Bby%252BSequential%252BVirtual%252BScreening%26aulast%3DEl-Zohairy%26aufirst%3DMariam%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05022021%26date%3D05042021%26date%3D16042021%26volume%3D6%26issue%3D16%26spage%3D10921%26epage%3D10935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Arimont</span>, <span class="hlFld-ContribAuthor ">Shan-Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Martine  Smit</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of Chemokine Receptor–Ligand Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 4735-4779. <a href="https://doi.org/10.1021/acs.jmedchem.6b01309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BAnalysis%252Bof%252BChemokine%252BReceptor%2525E2%252580%252593Ligand%252BInteractions%26aulast%3DArimont%26aufirst%3DMarta%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D31082016%26date%3D10032017%26date%3D22062017%26date%3D06022017%26volume%3D60%26issue%3D12%26spage%3D4735%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Susan  Danehower</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Robert G.  Ferris</span>, <span class="hlFld-ContribAuthor ">Vassil  Elitzin</span>, <span class="hlFld-ContribAuthor ">Douglas  Minick</span>, <span class="hlFld-ContribAuthor ">Matthew  Sharp</span>, <span class="hlFld-ContribAuthor ">Eugene  Stewart</span>, and <span class="hlFld-ContribAuthor ">Manon  Villeneuve</span>  . </span><span class="cited-content_cbyCitation_article-title">Biological and Structural Characterization of Rotamers of C–C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1296-1299. <a href="https://doi.org/10.1021/ml5004124" title="DOI URL">https://doi.org/10.1021/ml5004124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5004124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5004124%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiological%252Band%252BStructural%252BCharacterization%252Bof%252BRotamers%252Bof%252BC%2525E2%252580%252593C%252BChemokine%252BReceptor%252BType%252B5%252B%252528CCR5%252529%252BInhibitor%252BGSK214096%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01092014%26date%3D28102014%26date%3D12112014%26date%3D11122014%26date%3D28102014%26volume%3D5%26issue%3D12%26spage%3D1296%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianjin  An</span>, <span class="hlFld-ContribAuthor ">Jiefeng  Shen</span>, <span class="hlFld-ContribAuthor ">Nicholas  Butt</span>, <span class="hlFld-ContribAuthor ">Delong  Liu</span>, <span class="hlFld-ContribAuthor ">Yangang  Liu</span>, and <span class="hlFld-ContribAuthor ">Wanbin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Domino Reaction of Cyclic N-Sulfonylimines and Simple Aldehydes with trans-Perhydroindolic Acid as an Organocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (17)
                                     , 4496-4499. <a href="https://doi.org/10.1021/ol502033v" title="DOI URL">https://doi.org/10.1021/ol502033v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol502033v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol502033v%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BDomino%252BReaction%252Bof%252BCyclic%252BN-Sulfonylimines%252Band%252BSimple%252BAldehydes%252Bwith%252Btrans-Perhydroindolic%252BAcid%252Bas%252Ban%252BOrganocatalyst%26aulast%3DAn%26aufirst%3DQianjin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11072014%26date%3D20082014%26date%3D05092014%26volume%3D16%26issue%3D17%26spage%3D4496%26epage%3D4499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renato  Skerlj</span>, <span class="hlFld-ContribAuthor ">Gary  Bridger</span>, <span class="hlFld-ContribAuthor ">Yuanxi  Zhou</span>, <span class="hlFld-ContribAuthor ">Elyse  Bourque</span>, <span class="hlFld-ContribAuthor ">Ernest  McEachern</span>, <span class="hlFld-ContribAuthor ">Markus  Metz</span>, <span class="hlFld-ContribAuthor ">Curtis  Harwig</span>, <span class="hlFld-ContribAuthor ">Tong-Shuang  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Yang</span>, <span class="hlFld-ContribAuthor ">David  Bogucki</span>, <span class="hlFld-ContribAuthor ">Yongbao  Zhu</span>, <span class="hlFld-ContribAuthor ">Jonathan  Langille</span>, <span class="hlFld-ContribAuthor ">Duane  Veale</span>, <span class="hlFld-ContribAuthor ">Tuya  Ba</span>, <span class="hlFld-ContribAuthor ">Michael  Bey</span>, <span class="hlFld-ContribAuthor ">Ian  Baird</span>, <span class="hlFld-ContribAuthor ">Alan  Kaller</span>, <span class="hlFld-ContribAuthor ">Maria  Krumpak</span>, <span class="hlFld-ContribAuthor ">David  Leitch</span>, <span class="hlFld-ContribAuthor ">Michael  Satori</span>, <span class="hlFld-ContribAuthor ">Krystyna  Vocadlo</span>, <span class="hlFld-ContribAuthor ">Danielle  Guay</span>, <span class="hlFld-ContribAuthor ">Susan  Nan</span>, <span class="hlFld-ContribAuthor ">Helen  Yee</span>, <span class="hlFld-ContribAuthor ">Jason  Crawford</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Trevor  Wilson</span>, <span class="hlFld-ContribAuthor ">Bryon  Carpenter</span>, <span class="hlFld-ContribAuthor ">David  Gauthier</span>, <span class="hlFld-ContribAuthor ">Ron  MacFarland</span>, <span class="hlFld-ContribAuthor ">Renee  Mosi</span>, <span class="hlFld-ContribAuthor ">Veronique  Bodart</span>, <span class="hlFld-ContribAuthor ">Rebecca  Wong</span>, <span class="hlFld-ContribAuthor ">Simon  Fricker</span>, and <span class="hlFld-ContribAuthor ">Dominique  Schols</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Substituted Imidazolidinylpiperidinylbenzoic Acids as Chemokine Receptor 5 Antagonists: Potent Inhibitors of R5 HIV-1 Replication. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 8049-8065. <a href="https://doi.org/10.1021/jm401101p" title="DOI URL">https://doi.org/10.1021/jm401101p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401101p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401101p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BSubstituted%252BImidazolidinylpiperidinylbenzoic%252BAcids%252Bas%252BChemokine%252BReceptor%252B5%252BAntagonists%25253A%252BPotent%252BInhibitors%252Bof%252BR5%252BHIV-1%252BReplication%26aulast%3DSkerlj%26aufirst%3DRenato%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19072013%26date%3D03102013%26date%3D24102013%26volume%3D56%26issue%3D20%26spage%3D8049%26epage%3D8065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Karlström</span>, <span class="hlFld-ContribAuthor ">Gunnar  Nordvall</span>, <span class="hlFld-ContribAuthor ">Daniel  Sohn</span>, <span class="hlFld-ContribAuthor ">Andreas  Hettman</span>, <span class="hlFld-ContribAuthor ">Dominika  Turek</span>, <span class="hlFld-ContribAuthor ">Kristofer  Åhlin</span>, <span class="hlFld-ContribAuthor ">Annika  Kers</span>, <span class="hlFld-ContribAuthor ">Martina  Claesson</span>, <span class="hlFld-ContribAuthor ">Can  Slivo</span>, <span class="hlFld-ContribAuthor ">Yvonne  Lo-Alfredsson</span>, <span class="hlFld-ContribAuthor ">Carl  Petersson</span>, <span class="hlFld-ContribAuthor ">Galina  Bessidskaia</span>, <span class="hlFld-ContribAuthor ">Per H.  Svensson</span>, <span class="hlFld-ContribAuthor ">Tobias  Rein</span>, <span class="hlFld-ContribAuthor ">Eva  Jerning</span>, <span class="hlFld-ContribAuthor ">Åsa  Malmberg</span>, <span class="hlFld-ContribAuthor ">Charlotte  Ahlgen</span>, <span class="hlFld-ContribAuthor ">Colin  Ray</span>, <span class="hlFld-ContribAuthor ">Lauri  Vares</span>, <span class="hlFld-ContribAuthor ">Vladimir  Ivanov</span>, and <span class="hlFld-ContribAuthor ">Rolf  Johansson</span>  . </span><span class="cited-content_cbyCitation_article-title">Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (8)
                                     , 3177-3190. <a href="https://doi.org/10.1021/jm3012273" title="DOI URL">https://doi.org/10.1021/jm3012273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3012273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3012273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B7-Amino-5-thio-thiazolo%25255B4%25252C5-d%25255Dpyrimidines%252Bas%252BPotent%252Band%252BSelective%252BAntagonists%252Bof%252Bthe%252BFractalkine%252BReceptor%252B%252528CX3CR1%252529%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DSofia%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D29082012%26date%3D04042013%26date%3D25042013%26date%3D21032013%26volume%3D56%26issue%3D8%26spage%3D3177%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Don L.  Anderson</span>, <span class="hlFld-ContribAuthor ">Christopher  Aquino</span>, <span class="hlFld-ContribAuthor ">Brian A.  Chauder</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Robert  Ferris</span>, <span class="hlFld-ContribAuthor ">Terrence  Kenakin</span>, <span class="hlFld-ContribAuthor ">Cecilia S.  Koble</span>, <span class="hlFld-ContribAuthor ">Dan G.  Lang</span>, <span class="hlFld-ContribAuthor ">Maggie S  Mcintyre</span>, <span class="hlFld-ContribAuthor ">Jennifer  Peckham</span>, <span class="hlFld-ContribAuthor ">Christian  Watson</span>, <span class="hlFld-ContribAuthor ">Pat  Wheelan</span>, <span class="hlFld-ContribAuthor ">Andrew  Spaltenstein</span>, <span class="hlFld-ContribAuthor ">Mary B.  Wire</span>, <span class="hlFld-ContribAuthor ">Angilique  Svolto</span>, and <span class="hlFld-ContribAuthor ">Michael  Youngman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (11)
                                     , 3756-3767. <a href="https://doi.org/10.1021/jm200279v" title="DOI URL">https://doi.org/10.1021/jm200279v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200279v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200279v%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6538%26epage%3D6546%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B4%25252C4-Disubstituted%252BPiperidine-Based%252BC%2525E2%252580%252593C%252BChemokine%252BReceptor-5%252BInhibitors%252Bwith%252BHigh%252BPotency%252Bagainst%252BHuman%252BImmunodeficiency%252BVirus-1%252Band%252Ban%252BImproved%252Bhuman%252BEther-a-go-go%252BRelated%252BGene%252B%252528hERG%252529%252BProfile%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D27122010%26date%3D17052011%26date%3D09062011%26date%3D03052011%26volume%3D54%26issue%3D11%26spage%3D3756%26epage%3D3767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span> and <span class="hlFld-ContribAuthor ">Allan M.  Jordan</span>  . </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (10)
                                     , 3451-3479. <a href="https://doi.org/10.1021/jm200187y" title="DOI URL">https://doi.org/10.1021/jm200187y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200187y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200187y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMedicinal%252BChemist%2525E2%252580%252599s%252BToolbox%25253A%252BAn%252BAnalysis%252Bof%252BReactions%252BUsed%252Bin%252Bthe%252BPursuit%252Bof%252BDrug%252BCandidates%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18022011%26date%3D02052011%26date%3D26052011%26date%3D19042011%26volume%3D54%26issue%3D10%26spage%3D3451%26epage%3D3479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Stupple</span>, <span class="hlFld-ContribAuthor ">David V.  Batchelor</span>, <span class="hlFld-ContribAuthor ">Martin  Corless</span>, <span class="hlFld-ContribAuthor ">Patrick K.  Dorr</span>, <span class="hlFld-ContribAuthor ">David  Ellis</span>, <span class="hlFld-ContribAuthor ">David R.  Fenwick</span>, <span class="hlFld-ContribAuthor ">Sébastien R. G.  Galan</span>, <span class="hlFld-ContribAuthor ">Rhys M.  Jones</span>, <span class="hlFld-ContribAuthor ">Helen J.  Mason</span>, <span class="hlFld-ContribAuthor ">Donald S.  Middleton</span>, <span class="hlFld-ContribAuthor ">Manos  Perros</span>, <span class="hlFld-ContribAuthor ">Francesca  Perruccio</span>, <span class="hlFld-ContribAuthor ">Michelle Y.  Platts</span>, <span class="hlFld-ContribAuthor ">David C.  Pryde</span>, <span class="hlFld-ContribAuthor ">Deborah  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Nicholas N.  Smith</span>, <span class="hlFld-ContribAuthor ">Peter T.  Stephenson</span>, <span class="hlFld-ContribAuthor ">Robert  Webster</span>, <span class="hlFld-ContribAuthor ">Mike  Westby</span>, and <span class="hlFld-ContribAuthor ">Anthony  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV: The Discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (1)
                                     , 67-77. <a href="https://doi.org/10.1021/jm100978n" title="DOI URL">https://doi.org/10.1021/jm100978n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100978n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100978n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252BImidazopiperidine%252BSeries%252Bof%252BCCR5%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BHIV%25253A%252BThe%252BDiscovery%252Bof%252BN-%25257B%2525281S%252529-1-%2525283-Fluorophenyl%252529-3-%25255B%2525283-endo%252529-3-%2525285-isobutyryl-2-methyl-4%25252C5%25252C6%25252C7-tetrahydro-1H-imidazo%25255B4%25252C5-c%25255Dpyridin-1-yl%252529-8-azabicyclo%25255B3.2.1%25255Doct-8-yl%25255Dpropyl%25257Dacetamide%252B%252528PF-232798%252529%26aulast%3DStupple%26aufirst%3DPaul%2BA.%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D30072010%26date%3D03122010%26date%3D13012011%26volume%3D54%26issue%3D1%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khomson  Suttisintong</span>, <span class="hlFld-ContribAuthor ">Narongpol  Kaewchangwat</span>, <span class="hlFld-ContribAuthor ">Eknarin  Thanayupong</span>, <span class="hlFld-ContribAuthor ">Chakkrapan  Nerungsi</span>, <span class="hlFld-ContribAuthor ">Onsiri  Srikun</span>, <span class="hlFld-ContribAuthor ">Pornpan  Pungpo</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (18)
                                     , 1599-1620. <a href="https://doi.org/10.2174/1568026619666190712204050" title="DOI URL">https://doi.org/10.2174/1568026619666190712204050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712204050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712204050%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BHIV-1%252BEntry%252BInhibitors%25253A%252BFrom%252BSmall%252BMolecules%252Bto%252BPotent%252BAnti-HIV%252BAgents%26aulast%3DSuttisintong%26aufirst%3DKhomson%26date%3D2019%26volume%3D19%26issue%3D18%26spage%3D1599%26epage%3D1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tie-Gen  Chen</span>, <span class="hlFld-ContribAuthor ">Haolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>, <span class="hlFld-ContribAuthor ">Rohan R.  Merchant</span>, <span class="hlFld-ContribAuthor ">Courtney A.  Smith</span>, <span class="hlFld-ContribAuthor ">Tian  Qin</span>, <span class="hlFld-ContribAuthor ">Phil S.  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Quaternary Centers by Nickel-Catalyzed Cross-Coupling of Tertiary Carboxylic Acids and (Hetero)Aryl Zinc Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (8)
                                     , 2476-2480. <a href="https://doi.org/10.1002/ange.201814524" title="DOI URL">https://doi.org/10.1002/ange.201814524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201814524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201814524%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DQuaternary%252BCenters%252Bby%252BNickel-Catalyzed%252BCross-Coupling%252Bof%252BTertiary%252BCarboxylic%252BAcids%252Band%252B%252528Hetero%252529Aryl%252BZinc%252BReagents%26aulast%3DChen%26aufirst%3DTie-Gen%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D8%26spage%3D2476%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tie‐Gen  Chen</span>, <span class="hlFld-ContribAuthor ">Haolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>, <span class="hlFld-ContribAuthor ">Rohan R.  Merchant</span>, <span class="hlFld-ContribAuthor ">Courtney A.  Smith</span>, <span class="hlFld-ContribAuthor ">Tian  Qin</span>, <span class="hlFld-ContribAuthor ">Phil S.  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Quaternary Centers by Nickel‐Catalyzed Cross‐Coupling of Tertiary Carboxylic Acids and (Hetero)Aryl Zinc Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (8)
                                     , 2454-2458. <a href="https://doi.org/10.1002/anie.201814524" title="DOI URL">https://doi.org/10.1002/anie.201814524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201814524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201814524%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DQuaternary%252BCenters%252Bby%252BNickel%2525E2%252580%252590Catalyzed%252BCross%2525E2%252580%252590Coupling%252Bof%252BTertiary%252BCarboxylic%252BAcids%252Band%252B%252528Hetero%252529Aryl%252BZinc%252BReagents%26aulast%3DChen%26aufirst%3DTie%25E2%2580%2590Gen%26date%3D2019%26volume%3D58%26issue%3D8%26spage%3D2454%26epage%3D2458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">4-(Hetero)Arylpiperidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 155-193. <a href="https://doi.org/10.1002/9781118686263.ch5" title="DOI URL">https://doi.org/10.1002/9781118686263.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch5%26sid%3Dliteratum%253Aachs%26atitle%3D4-%252528Hetero%252529Arylpiperidines%26date%3D2018%26date%3D2018%26spage%3D155%26epage%3D193%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harshil R.  Shah</span>, <span class="hlFld-ContribAuthor ">Jignasa Ketan  Savjani</span>. </span><span class="cited-content_cbyCitation_article-title">Recent updates for designing CCR5 antagonists as anti-retroviral agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>147 </em>, 115-129. <a href="https://doi.org/10.1016/j.ejmech.2018.01.085" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.085%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bupdates%252Bfor%252Bdesigning%252BCCR5%252Bantagonists%252Bas%252Banti-retroviral%252Bagents%26aulast%3DShah%26aufirst%3DHarshil%2BR.%26date%3D2018%26volume%3D147%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Shankariah  Gundeti</span>, <span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Haeil  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 254-260. <a href="https://doi.org/10.1016/j.bmc.2016.10.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5-nitropyrimidine%252Bderivatives%252Bbearing%252Bendo-azabicyclic%252Balcohols%25252Famines%252Bas%252Bpotent%252BGPR119%252Bagonists%26aulast%3DFang%26aufirst%3DYuanying%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle B.  Kim</span>, <span class="hlFld-ContribAuthor ">Kyle E.  Giesler</span>, <span class="hlFld-ContribAuthor ">Yesim A.  Tahirovic</span>, <span class="hlFld-ContribAuthor ">Valarie M.  Truax</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">Lawrence J.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (12)
                                     , 1377-1392. <a href="https://doi.org/10.1080/13543784.2016.1254615" title="DOI URL">https://doi.org/10.1080/13543784.2016.1254615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2016.1254615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2016.1254615%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DCCR5%252Breceptor%252Bantagonists%252Bin%252Bpreclinical%252Bto%252Bphase%252BII%252Bclinical%252Bdevelopment%252Bfor%252Btreatment%252Bof%252BHIV%26aulast%3DKim%26aufirst%3DMichelle%2BB.%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D12%26spage%3D1377%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Junker</span>, <span class="hlFld-ContribAuthor ">Artur Kamil  Kokornaczyk</span>, <span class="hlFld-ContribAuthor ">Ann Kathrin  Strunz</span>, <span class="hlFld-ContribAuthor ">Bernhard  Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 187-241. <a href="https://doi.org/10.1007/7355_2014_40" title="DOI URL">https://doi.org/10.1007/7355_2014_40</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_40%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252Band%252BDual%252BTargeting%252Bof%252BCCR2%252Band%252BCCR5%252BReceptors%25253A%252BA%252BCurrent%252BOverview%26aulast%3DJunker%26aufirst%3DAnna%26date%3D2014%26date%3D2014%26spage%3D187%26epage%3D241%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemokines%26aulast%3DTschammer%26aufirst%3DNuska%26date%3D2015%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nick J.  Wardle</span>, <span class="hlFld-ContribAuthor ">Harry R.  Hudson</span>, <span class="hlFld-ContribAuthor ">Ray W.  Matthews</span>, <span class="hlFld-ContribAuthor ">Christine M.  Nunn</span>, <span class="hlFld-ContribAuthor ">Cherelyn  Vella</span>, <span class="hlFld-ContribAuthor ">S. W. Annie  Bligh</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Replication of R5 HIV-1 Isolates in vitro by a Small-Molecule Reagent Targeting HIV-1 Protease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 719-721. <a href="https://doi.org/10.1002/cmdc.201300051" title="DOI URL">https://doi.org/10.1002/cmdc.201300051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300051%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DEnhanced%252BReplication%252Bof%252BR5%252BHIV-1%252BIsolates%252Bin%2525E2%252580%252585vitro%252Bby%252Ba%252BSmall-Molecule%252BReagent%252BTargeting%252BHIV-1%252BProtease%26aulast%3DWardle%26aufirst%3DNick%2BJ.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3D719%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuan-Anh N.  Pham</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Jun  Luo</span>, <span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Haeil  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (5)
                                     , 1349-1356. <a href="https://doi.org/10.1016/j.bmc.2012.12.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-disubstituted%252Bquinazoline%252Banalogues%252Bas%252BGPR119%252Bagonists%26aulast%3DPham%26aufirst%3DTuan-Anh%2BN.%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1349%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Tuan-Anh N.  Pham</span>, <span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Haeil  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 1519-1521. <a href="https://doi.org/10.1016/j.bmcl.2012.12.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B5-nitropyrimidine%252Banalogs%252Bwith%252Bazabicyclic%252Bsubstituents%252Bas%252BGPR119%252Bagonists%26aulast%3DYang%26aufirst%3DZunhua%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D1519%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henri-Philippe  Husson</span>, <span class="hlFld-ContribAuthor ">Jacques  Royer</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">2,5-Dimethoxytetrahydrofuran. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,<a href="https://doi.org/10.1002/047084289X.rd289.pub2" title="DOI URL">https://doi.org/10.1002/047084289X.rd289.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rd289.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rd289.pub2%26sid%3Dliteratum%253Aachs%26atitle%3D2%25252C5-Dimethoxytetrahydrofuran%26aulast%3DHusson%26aufirst%3DHenri-Philippe%26date%3D2012%26date%3D2012%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandro  Cacchi</span>, <span class="hlFld-ContribAuthor ">Enrico  Morera</span>, <span class="hlFld-ContribAuthor ">Giorgio  Ortar</span>. </span><span class="cited-content_cbyCitation_article-title">Discussion Addendum for: Palladium-Catalyzed Reduction of Vinyl Trifluoromethanesulfonates to Alkenes: Cholesta-3,5-Diene. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 260-290. <a href="https://doi.org/10.1002/0471264229.os088.25" title="DOI URL">https://doi.org/10.1002/0471264229.os088.25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264229.os088.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264229.os088.25%26sid%3Dliteratum%253Aachs%26atitle%3DDiscussion%252BAddendum%252Bfor%25253A%252BPalladium-Catalyzed%252BReduction%252Bof%252BVinyl%252BTrifluoromethanesulfonates%252Bto%252BAlkenes%25253A%252BCholesta-3%25252C5-Diene%26aulast%3DCacchi%26aufirst%3DSandro%26date%3D2011%26date%3D2012%26spage%3D260%26epage%3D290%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BSyntheses%26date%3D2003%26date%3D2003%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Tallant</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">George A.  Freeman</span>, <span class="hlFld-ContribAuthor ">Robert G.  Ferris</span>, <span class="hlFld-ContribAuthor ">Mark P.  Edelstein</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Pat J.  Wheelan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (5)
                                     , 1394-1398. <a href="https://doi.org/10.1016/j.bmcl.2011.01.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B2-phenyl-1%25252C4-butanediamine-based%252BCCR5%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252BHIV-1%26aulast%3DTallant%26aufirst%3DMatthew%2BD.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1394%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Jennifer  Peckham</span>, <span class="hlFld-ContribAuthor ">Mark  Edelstein</span>, <span class="hlFld-ContribAuthor ">Robert  Ferris</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Andrew  Spaltenstein</span>, <span class="hlFld-ContribAuthor ">Pat  Wheelan</span>, <span class="hlFld-ContribAuthor ">Zhiping  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): Optimization of the amine portion. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (24)
                                     , 7397-7400. <a href="https://doi.org/10.1016/j.bmcl.2010.10.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-benzyl-N%2525E2%252580%2525B2-%2525284-pipyridinyl%252529urea%252BCCR5%252Bantagonists%252Bas%252Banti-HIV-1%252Bagents%252B%252528I%252529%25253A%252BOptimization%252Bof%252Bthe%252Bamine%252Bportion%26aulast%3DDuan%26aufirst%3DMaosheng%26date%3D2010%26volume%3D20%26issue%3D24%26spage%3D7397%26epage%3D7400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Jennifer  Peckham</span>, <span class="hlFld-ContribAuthor ">Mark  Edelstein</span>, <span class="hlFld-ContribAuthor ">Robert  Ferris</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Andrew  Spaltenstein</span>, <span class="hlFld-ContribAuthor ">Pat  Wheelan</span>, <span class="hlFld-ContribAuthor ">Zhiping  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): Modification of the acyl portion. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (24)
                                     , 7401-7404. <a href="https://doi.org/10.1016/j.bmcl.2010.10.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-benzyl-N%2525E2%252580%2525B2-%2525284-pipyridinyl%252529urea%252BCCR5%252Bantagonists%252Bas%252Banti-HIV-1%252Bagents%252B%252528II%252529%25253A%252BModification%252Bof%252Bthe%252Bacyl%252Bportion%26aulast%3DDuan%26aufirst%3DMaosheng%26date%3D2010%26volume%3D20%26issue%3D24%26spage%3D7401%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hu-Shan  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong-Zhi  Feng</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel (S)-α-phenyl-γ-amino butanamide containing CCR5 antagonists via functionality inversion approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2219-2223. <a href="https://doi.org/10.1016/j.bmcl.2010.02.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252B%252528S%252529-%2525CE%2525B1-phenyl-%2525CE%2525B3-amino%252Bbutanamide%252Bcontaining%252BCCR5%252Bantagonists%252Bvia%252Bfunctionality%252Binversion%252Bapproach%26aulast%3DZhang%26aufirst%3DHu-Shan%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziza</span>, <span class="hlFld-ContribAuthor ">Bakr F.  Abdel-Wahab</span>, <span class="hlFld-ContribAuthor ">Farid A.  Badria</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis and Antiviral Activity of (1
              E
              ,2
              Z
              ,3
              E
              )-1-(Piperidin-1-yl)-1-(arylhydrazono)-2-[(benzoyl/benzothiazol- 2-oyl)hydrazono]-4-(aryl
              1
              )but-3-enes. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2010,</strong> <em>343 </em>
                                    (3)
                                     , 152-159. <a href="https://doi.org/10.1002/ardp.200900195" title="DOI URL">https://doi.org/10.1002/ardp.200900195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.200900195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.200900195%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DStereoselective%252BSynthesis%252Band%252BAntiviral%252BActivity%252Bof%252B%2525281%252BE%252B%25252C2%252BZ%252B%25252C3%252BE%252B%252529-1-%252528Piperidin-1-yl%252529-1-%252528arylhydrazono%252529-2-%25255B%252528benzoyl%25252Fbenzothiazol-%252B2-oyl%252529hydrazono%25255D-4-%252528aryl%252B1%252B%252529but-3-enes%26aulast%3DAbdel-Aziza%26aufirst%3DHatem%2BA.%26date%3D2010%26volume%3D343%26issue%3D3%26spage%3D152%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Christopher  Aquino</span>, <span class="hlFld-ContribAuthor ">George F.  Dorsey</span>, <span class="hlFld-ContribAuthor ">Robert  Ferris</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>. </span><span class="cited-content_cbyCitation_article-title">4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (17)
                                     , 4988-4992. <a href="https://doi.org/10.1016/j.bmcl.2009.07.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.07.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.07.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.07.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4%25252C4-Disubstituted%252Bcyclohexylamine%252Bbased%252BCCR5%252Bchemokine%252Breceptor%252Bantagonists%252Bas%252Banti-HIV-1%252Bagents%26aulast%3DDuan%26aufirst%3DMaosheng%26date%3D2009%26volume%3D19%26issue%3D17%26spage%3D4988%26epage%3D4992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Christopher  Aquino</span>, <span class="hlFld-ContribAuthor ">Robert  Ferris</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, <span class="hlFld-ContribAuthor ">Cecilia  Koble</span>, <span class="hlFld-ContribAuthor ">Pat  Wheelan</span>, <span class="hlFld-ContribAuthor ">Chris  Watson</span>, <span class="hlFld-ContribAuthor ">Michael  Youngman</span>. </span><span class="cited-content_cbyCitation_article-title">[2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (6)
                                     , 1610-1613. <a href="https://doi.org/10.1016/j.bmcl.2009.02.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%25255B2-%2525284-Phenyl-4-piperidinyl%252529ethyl%25255Damine%252Bbased%252BCCR5%252Bantagonists%25253A%252Bderivatizations%252Bat%252Bthe%252BN-terminal%252Bof%252Bthe%252Bpiperidine%252Bring%26aulast%3DDuan%26aufirst%3DMaosheng%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D1610%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Generalized modular structure of compounds described in this work. (b) Six-feature pharmacophore model for CCR5 antagonism constructed via Catalyst. Software version Catalyst v4.5, 2000, Accelrys, Inc., San Diego, CA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffolds <b>A</b>−<b>H</b> described in this work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a)Toluene, diethyl carbonate, NaH, reflux; (b) DMF, <i>t</i>-BuOK, 2-(2-bromoethyl)-1,3-dioxolane, −78 °C → rt, o/n; (c) MeOH/NH<sub>4</sub>OH, Ra−Ni, 60 psi H<sub>2</sub>, 50 °C; (d) THF/ethyl ether, CH<sub>3</sub>MgI, rt; (e) THF/ethyl ether, LAH, reflux; (f) THF, benzenesulfonyl chloride, DIEA; (g) 10% HCl in THF; (h) dichloroethane, 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, NaBH(OAc)<sub>3</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a)THF, <i>t</i>-BuLi, −78 °C, 1-(benzyl)-3-pyrroldinone or 1-(benzyl)-4-piperidinone; (b) DMF, NaH, allyl bromide; (c) toluene, 1-chloroethyl chloroformate; (d) MeOH, K<sub>2</sub>CO<sub>3</sub>; (e) THF, (Boc)<sub>2</sub>O, TEA; (f) THF, OsO<sub>4</sub>, NMO; (g) THF/H<sub>2</sub>O, NaIO<sub>4</sub>; (h) DCE, amine, NaBH(OAc)<sub>3</sub>; (i) TFA/DCM (1/4); (j) DCM, acid chloride, polystyrene-DIEA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) THF, LHMDS, methyl bromoacetate, −78 °C, chromatographic separation; (b) MeOH, NH<sub>4</sub>OH, H<sub>2</sub>, 40 psi, Ra−Ni; rt; (c) THF, NaH, BnBr; (d) toluene, DIBAL; (e) DCE, amine, NaBH(OAc)<sub>3</sub>; (f) THF, LAH; (g) DMF, HATU, DIEA, acid; (h) DCM, Dess−Martin periodane; (i) THF, LHMDS, 2-(3-bromopropoxy)tetrahydro-2<i>H</i>-pyran; (j) 10% HCl in dioxane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) THF, NaH, Br-(CH<sub>2</sub>)<sub>3</sub>-O-THP; (b) dioxane, Triton B, ethyl acrylate; (c) MeOH, NH<sub>4</sub>OH, H<sub>2</sub>, 40 psi, Ra−Ni; rt; (d) THF, NaH, C<sub>6</sub>H<sub>5</sub>CH<sub>2</sub>Cl; (e) 10% HCl in THF; (f) DCM, MsCl, TEA; (g) DMSO, amines, 100 °C; (h) THF, LAH; (i) DCM, triphenyl phosphine, DEAD; (j) DCM, DIEA, C<sub>6</sub>H<sub>5</sub>COCl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) THF, (Boc)<sub>2</sub>O, TEA; (b) toluene, DIBAL in toluene, −78 °C to −35 °C, 2.5 h; (c) THF, <i>t</i>-BuOK, methyloxymethyl triphenylphosphonium chloride, 0 to 60 °C over 2 h; (d) water/acetone, <i>p</i>-TsOH, rt; (e) DCM, Dess−Martin periodinane, <i>t</i>-BuOH, rt; (f) toluene, KHMDS, (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>NPh; (g) CH<sub>3</sub>CN, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, (CH<sub>3</sub>)<sub>2</sub>NH·BH<sub>3</sub>, 65 °C, sealed tube, overnight; (h) THF, 9-BBN, reflux, o/n; (i) NaOH aq, H<sub>2</sub>O<sub>2</sub>; (k) 1-chloro-3-iodobenzene, ethyl ether, magnesium turnings, rt, add to cyano(1-Boc-4-piperidinylidene)acetate in THF, CuI; (l) ethanol, sodium hydroxide, rt, 1 M HCl workup; (m) acetonitrile, Cu<sub>2</sub>O, reflux, 30 min; (n) DCM, −30 °C, DIBAL in DCM; (p) dichloroethane, sodium triacetoxyborohydride.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/medium/jm-2008-00598a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) dichloromethane, (Boc)<sub>2</sub>O, TEA; (b) toluene, DIBAL in toluene, −78 °C to −35 °C, 2.5 h; (c) DMF, NaH, trimethylphosphonoacetate; (d) MeOH, H<sub>2</sub>, Pd−C, overnight; (e) toluene, DIBAL in toluene, −78 °C, 20 min; (f) DCM, Dess−Martin periodinane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-20/jm800598a/production/images/large/jm-2008-00598a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800598a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazareno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strizki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, R.</span><span> </span><span class="NLM_article-title">Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[4-{2-methoxy-1(<i>R</i>)-4-(trifluoromethyl)phenyl}ethyl-3(<i>S</i>)-methyl-1-piperazinyl]-4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">2405</span> <span class="NLM_lpage">2408</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0304515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2405-2408&author=J.+R.+Tagatauthor=S.+W.+McCombieauthor=D.+Nazarenoauthor=M.+A.+Labroliauthor=Y.+Xiaoauthor=R.+W.+Steensmaauthor=J.+M.+Strizkiauthor=B.+M.+Baroudyauthor=K.+Coxauthor=J.+Lachowiczauthor=G.+Vartyauthor=R.+Watkins&title=Piperazine-Based+CCR5+Antagonists+as+HIV-1+Inhibitors.+IV.+Discovery+of+1-%5B%284%2C6-Dimethyl-5-pyrimidinyl%29carbonyl%5D-4-%5B4-%7B2-methoxy-1%28R%29-4-%28trifluoromethyl%29phenyl%7Dethyl-3%28S%29-methyl-1-piperazinyl%5D-4-methylpiperidine+%28Sch-417690%2FSch-D%29%2C+a+Potent%2C+Highly+Selective%2C+and+Orally+Bioavailable+CCR5+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm0304515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0304515%26sid%3Dliteratum%253Aachs%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DMcCombie%26aufirst%3DS.%2BW.%26aulast%3DNazareno%26aufirst%3DD.%26aulast%3DLabroli%26aufirst%3DM.%2BA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSteensma%26aufirst%3DR.%2BW.%26aulast%3DStrizki%26aufirst%3DJ.%2BM.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DWatkins%26aufirst%3DR.%26atitle%3DPiperazine-Based%2520CCR5%2520Antagonists%2520as%2520HIV-1%2520Inhibitors.%2520IV.%2520Discovery%2520of%25201-%255B%25284%252C6-Dimethyl-5-pyrimidinyl%2529carbonyl%255D-4-%255B4-%257B2-methoxy-1%2528R%2529-4-%2528trifluoromethyl%2529phenyl%257Dethyl-3%2528S%2529-methyl-1-piperazinyl%255D-4-methylpiperidine%2520%2528Sch-417690%252FSch-D%2529%252C%2520a%2520Potent%252C%2520Highly%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520CCR5%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2405%26epage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aramaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuze, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, M.</span><span> </span><span class="NLM_article-title">Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">2037</span> <span class="NLM_lpage">2048</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509703" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2037-2048&author=M.+Setoauthor=K.+Aikawaauthor=N.+Miyamotoauthor=Y.+Aramakiauthor=N.+Kanzakiauthor=K.+Takashimaauthor=Y.+Kuzeauthor=Y.+Iizawaauthor=M.+Babaauthor=M.+Shiraishi&title=Highly+Potent+and+Orally+Active+CCR5+Antagonists+as+Anti-HIV-1+Agents%3A+Synthesis+and+Biological+Activities+of+1-Benzazocine+Derivatives+Containing+a+Sulfoxide+Moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety</span></div><div class="casAuthors">Seto, Masaki; Aikawa, Katsuji; Miyamoto, Naoki; Aramaki, Yoshio; Kanzaki, Naoyuki; Takashima, Katsunori; Kuze, Yoji; Iizawa, Yuji; Baba, Masanori; Shiraishi, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. modification was performed on the orally bioavailable and potent CCR5 antagonist sulfoxide compd. I, mainly focusing on replacement of the [6,7]-fused 1-benzazepine nucleus.  Ring-expanded [6,8]-, [6,9]-, and [6,10]-fused compds. contg. S-sulfoxide moieties were prepd. and evaluated for biol. activities which led to 1-benzazocine and 1-benzazonine compds. that exhibited potent inhibitory activities.  1-Benzazocine compds. possessing the S-sulfoxide moiety showed greater potency than I in a fusion assay.  Further investigation in a multi-round infection assay showed that the 1-isobutyl-1-benzazocine compd. II, contg. the S-[[(1-propyl-1H-imidazol)-5-yl]methyl]sulfinyl group, showed the most potent anti-HIV-1 activity.  II (TAK-652) also inhibited the replication of six macrophage-tropic HIV-1 clin. isolates in peripheral blood mononuclear cells.  It was also absorbed after oral administration in rats, dogs, and monkeys and was thus selected as a clin. candidate.  The synthesis and biol. activity of II and derivs. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6VVfNAhytC7Vg90H21EOLACvtfcHk0liz__P2Dxw6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVCjsrY%253D&md5=e579dea40031ca3ac3d7b2d96875ab4c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm0509703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509703%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DAramaki%26aufirst%3DY.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DKuze%26aufirst%3DY.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DShiraishi%26aufirst%3DM.%26atitle%3DHighly%2520Potent%2520and%2520Orally%2520Active%2520CCR5%2520Antagonists%2520as%2520Anti-HIV-1%2520Agents%253A%2520Synthesis%2520and%2520Biological%2520Activities%2520of%25201-Benzazocine%2520Derivatives%2520Containing%2520a%2520Sulfoxide%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2037%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span> </span><span class="NLM_article-title">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=15850827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=239-271&author=A.+Woodauthor=D.+Armour&title=The+discovery+of+the+CCR5+receptor+antagonist%2C+UK-427%2C857%2C+a+new+agent+for+the+treatment+of+HIV+infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span></div><div class="casAuthors">Wood, Anthony; Armour, Duncan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-271</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The drug discovery program that led to the identification of UK-427,857, a prototype CCR5 antagonist with excellent potency against lab-adapted and primary HIV-1 isolates, as a clin. candidate for the treatment of HIV is described.  In particular, strategies for minimizing cardiac toxicity while maintaining ADME properties commensurate with low dose are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJQwMygW-grVg90H21EOLACvtfcHk0liz__P2Dxw6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D&md5=8c4bb50b02b7e6d8cfa13d844e39017c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26aulast%3DArmour%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">CCR5 chemokine receptors: gatekeepers of HIV-1 infection</span> <span class="citation_source-journal">Curr. Drug Targets: Inf. Disord.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">265</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.2174%2F1568005023342489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=12462129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsV2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=265-278&author=W.+M.+Kazmierskiauthor=L.+Booneauthor=W.+Lawrenceauthor=C.+Watsonauthor=T.+Kenakin&title=CCR5+chemokine+receptors%3A+gatekeepers+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">CCR5 chemokine receptors: gatekeepers of HIV-1 infection</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Boone, Larry; Lawrence, Wendell; Watson, Chris; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-278</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  With the discovery that CCR5 is the crit. protein required for infection by M-tropic HIV, have come huge research efforts, both in academia and industry, to try to exploit this finding.  Thus, research advances in the fields of virol., structural protein chem., and receptor pharmacol. have combined to add a new understanding to the process of HIV fusion and possible mechanisms to prevent HIV entry.  This review will approach this field from a receptor pharmacol. viewpoint and outline some concepts of receptor allosterism and protein-protein interaction which may be relevant to CCR5 blockade.  Many of these ideas may be explored in a practical sense with the advent of new small mol. CCR5 inhibitors currently entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGnKY0SACfMrVg90H21EOLACvtfcHk0liz__P2Dxw6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsV2htLw%253D&md5=494c7dfa285e6431b8e4f75d2b14f260</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1568005023342489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005023342489%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DCCR5%2520chemokine%2520receptors%253A%2520gatekeepers%2520of%2520HIV-1%2520infection%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Inf.%2520Disord.%26date%3D2002%26volume%3D2%26spage%3D265%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAnda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">2663</span> <span class="NLM_lpage">2676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2663-2676&author=W.+Kazmierskiauthor=N.+Bifulcoauthor=H.+Yangauthor=L.+Booneauthor=F.+DeAndaauthor=C.+Watsonauthor=T.+Kenakin&title=Recent+progress+in+discovery+of+small-molecule+CCR5+chemokine+receptor+ligands+as+HIV-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DBifulco%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DDeAnda%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DRecent%2520progress%2520in%2520discovery%2520of%2520small-molecule%2520CCR5%2520chemokine%2520receptor%2520ligands%2520as%2520HIV-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2663%26epage%3D2676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAnda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors. [Erratum to document cited in CA139:332100]</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">4155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4155&author=W.+Kazmierskiauthor=N.+Bifulcoauthor=H.+Yangauthor=L.+Booneauthor=F.+DeAndaauthor=C.+Watsonauthor=T.+Kenakin&title=Recent+progress+in+discovery+of+small-molecule+CCR5+chemokine+receptor+ligands+as+HIV-1+inhibitors.+%5BErratum+to+document+cited+in+CA139%3A332100%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DBifulco%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DL.%26aulast%3DDeAnda%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DRecent%2520progress%2520in%2520discovery%2520of%2520small-molecule%2520CCR5%2520chemokine%2520receptor%2520ligands%2520as%2520HIV-1%2520inhibitors.%2520%255BErratum%2520to%2520document%2520cited%2520in%2520CA139%253A332100%255D%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span> </span><span class="NLM_article-title">Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">13</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1111%2Fj.1747-0285.2005.00319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=16492145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=13-26&author=W.+M.+Kazmierskiauthor=T.+P.+Kenakinauthor=K.+S.+Gudmundsson&title=Peptide%2C+peptidomimetic+and+small-molecule+drug+discovery+targeting+HIV-1+host-cell+attachment+and+entry+through+gp120%2C+gp41%2C+CCR5+and+CXCR4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Kenakin, Terry P.; Gudmundsson, Kristjan S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  This review highlights selected examples of peptide, peptidomimetic and small-mol. drug discovery targeting HIV-1 to advance novel anti-HIV pharmaceuticals that inhibit initial stages of the viral cycle; namely, attachment and entry.  Some of these approaches have culminated in the development of peptide-based drugs, while other have exploited peptides as enabling tools toward the identification of small-mol. lead compds.  Both of these conceptually different approaches have facilitated lead optimization of mols. with complementary and often surprising anti-HIV pharmacol. properties, supporting their role in pharmaceutical development.  Furthermore, such mols. enabled mechanistic elucidation of viral attachment and entry and provided addnl. insights toward achieving the desired drug profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nkSa0geKc7Vg90H21EOLACvtfcHk0lhbqqeGWRyMMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7s%253D&md5=78456a867f86f18501f3f02009444a8c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00319.x%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26atitle%3DPeptide%252C%2520peptidomimetic%2520and%2520small-molecule%2520drug%2520discovery%2520targeting%2520HIV-1%2520host-cell%2520attachment%2520and%2520entry%2520through%2520gp120%252C%2520gp41%252C%2520CCR5%2520and%2520CXCR4%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, P. L.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of new CCR5 and CXCR4 chemokine receptor antagonists as inhibitors of HIV-1 entry. Part 2</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infective Agents</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.2174%2F1568012053506981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=133-152&author=W.+M.+Kazmierskiauthor=J.+P.+Peckhamauthor=M.+Duanauthor=T.+P.+Kenakinauthor=S.+Jenkinsonauthor=K.+S.+Gudmundssonauthor=S.+C.+Piscitelliauthor=P.+L.+Feldman&title=Recent+progress+in+the+discovery+of+new+CCR5+and+CXCR4+chemokine+receptor+antagonists+as+inhibitors+of+HIV-1+entry.+Part+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of new CCR5 and CXCR4 chemokine receptor antagonists as inhibitors of HIV-1 entry. Part 2</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Peckham, Jennifer P.; Duan, Maosheng; Kenakin, Terry P.; Jenkinson, Stephen; Gudmundsson, Kristjan S.; Piscitelli, Stephen C.; Feldman, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review addresses key medicinal chem. issues relevant in the discovery and development of CCR5 and CXCR4 antagonists as anti-HIV drugs.  Recent progress in the discovery and development of such antagonists, SAR and clin. status are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6-6WXVA7DY7Vg90H21EOLACvtfcHk0lhbqqeGWRyMMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtrs%253D&md5=a0076b06de22e5bc4c2ce5ad5a4ad74c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568012053506981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012053506981%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520new%2520CCR5%2520and%2520CXCR4%2520chemokine%2520receptor%2520antagonists%2520as%2520inhibitors%2520of%2520HIV-1%2520entry.%2520Part%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infective%2520Agents%26date%3D2005%26volume%3D4%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span> </span><span class="NLM_article-title">Small molecule CCR5 and CXCR4-based viral entry inhibitors for anti-HIV therapy currently in development</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">301</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=301-320&author=W.+M.+Kazmierskiauthor=K.+S.+Gudmundssonauthor=S.+C.+Piscitelli&title=Small+molecule+CCR5+and+CXCR4-based+viral+entry+inhibitors+for+anti-HIV+therapy+currently+in+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26atitle%3DSmall%2520molecule%2520CCR5%2520and%2520CXCR4-based%2520viral%2520entry%2520inhibitors%2520for%2520anti-HIV%2520therapy%2520currently%2520in%2520development%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D301%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tsibris, A. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuritzkes, D. R.</span><span> </span><span class="NLM_article-title">Chemokine antagonists as therapeutics: focus on HIV-1</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">445</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2007&pages=445-459&author=A.+M.+N.+Tsibrisauthor=D.+R.+Kuritzkes&title=Chemokine+antagonists+as+therapeutics%3A+focus+on+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsibris%26aufirst%3DA.%2BM.%2BN.%26aulast%3DKuritzkes%26aufirst%3DD.%2BR.%26atitle%3DChemokine%2520antagonists%2520as%2520therapeutics%253A%2520focus%2520on%2520HIV-1%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2007%26volume%3D58%26spage%3D445%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span> </span><span class="NLM_article-title">Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">2851</span> <span class="NLM_lpage">2857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060009x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2851-2857&author=A.+Palaniauthor=J.+R.+Tagat&title=Discovery+and+Development+of+Small-Molecule+Chemokine+Coreceptor+CCR5+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists</span></div><div class="casAuthors">Palani, Anandan; Tagat, Jayaram R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2851-2857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the discovery and development of small-mol. chemokine coreceptor CCR5 antagonists for treatment of HIV infections and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNiMYyMzPNn7Vg90H21EOLACvtfcHk0lgUxm5DJQHrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslKlu7k%253D&md5=bdbc44ab09ac0fedc6b270fba34f4ce0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060009x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060009x%26sid%3Dliteratum%253Aachs%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Small-Molecule%2520Chemokine%2520Coreceptor%2520CCR5%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2851%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span> </span><span class="NLM_article-title">CCR5 antagonists: Host-targeted antivirals for the treatment of HIV infection</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">339</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=339-354&author=M.+Westbyauthor=E.+van+der+Ryst&title=CCR5+antagonists%3A+Host-targeted+antivirals+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestby%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26atitle%3DCCR5%2520antagonists%253A%2520Host-targeted%2520antivirals%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2005%26volume%3D16%26spage%3D339%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Barnum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smellie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprague, P.</span><span> </span><span class="NLM_article-title">Identification of Common Functional Configurations Among Molecules</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">563</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci950273r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADyaK28Xis1yjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1996&pages=563-571&author=D.+Barnumauthor=J.+Greeneauthor=A.+Smellieauthor=P.+Sprague&title=Identification+of+Common+Functional+Configurations+Among+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Common Functional Configurations Among Molecules</span></div><div class="casAuthors">Barnum, Doug; Greene, Jonathan; Smellie, Andrew; Sprague, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-71</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new algorithm for identifying three-dimensional configurations of chem. features common to a set of mols. is described.  The algorithm scores each configuration based both on the degree to which it is common to the input set and its estd. rarity.  The algorithm can be applied to mols. with large (several hundred) conformational models.  Results from the application of this algorithm to three data sets are discussed: PAF antagonists, HIV reverse transcriptase inhibitors, and HIV protease inhibitors.  Of particular interest is a common configuration identified for a set of HIV reverse transcriptase inhibitors; this configuration is shared by two new, potent inhibitors that were recently described in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq51RMW7hGC_LVg90H21EOLACvtfcHk0lgUxm5DJQHrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1yjsLw%253D&md5=39566bdbd6895c8b76145ba25471abf2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fci950273r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci950273r%26sid%3Dliteratum%253Aachs%26aulast%3DBarnum%26aufirst%3DD.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DSmellie%26aufirst%3DA.%26aulast%3DSprague%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520Common%2520Functional%2520Configurations%2520Among%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1996%26volume%3D36%26spage%3D563%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">1268</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1124%2Fmol.104.008565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=15644495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=1268-1282&author=C.+Watsonauthor=S.+Jenkinsonauthor=W.+Kazmierskiauthor=T.+Kenakin&title=The+CCR5+receptor-based+mechanism+of+action+of+873140%2C+a+potent+allosteric+noncompetitive+HIV+entry+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor</span></div><div class="casAuthors">Watson, Christian; Jenkinson, Stephen; Kazmierski, Wieslaw; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1268-1282</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">4-{[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenyl]oxy}benzoic acid hydrochloride (873140) is a potent noncompetitive allosteric antagonist of the CCR5 receptor (pKB = 8.6±0.07; 95% Cl, 8.5 to 8.8) with concomitantly potent antiviral effects for HIV-1.  In this article, the receptor-based mechanism of action of 873140 is compared with four other noncompetitive allosteric antagonists of CCR5.  Although (Z)-(4-bromophenyl){1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1,4'-bipiperidin-4-yl}methanone O-ethyloxime (Sch-C; SCH 351125), 4,6-dimethyl-5-{[4-methyl-4-((3S)-3-methyl-4-{(1R)-2-(methyloxy)-1-[4-(trifluoromethyl)phenyl]ethyl}-1-piperazinyl)-1-piperidinyl]carbonyl}pyrimidine (Sch-D; SCH 417,690), 4,4-difluoro-N-((1S)-3-{(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenyl-propyl)cyclohexanecarboxamide (UK-427,857), and N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclo-hepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride (TAK779) blocked the binding of both chemokines 125I-MIP-1α (also known as 125I-CCL3, 125I-LD78) and 125I-RANTES (125I-CCL5), 873140 was an ineffectual antagonist of 125I-RANTES (regulated on activation normal T cell expressed and secreted) binding (but did block binding of 125I-MIP-1α).  Furthermore, 873140 blocked the calcium response effects of CCR5 activation by CCL5 (RANTES) (as did the other antagonists), indicating a unique divergence of blockade of function and binding with this antagonist.  The antagonism of CCR5 by 873140 is saturable and probe-dependent, consistent with an allosteric mechanism of action.  The blockade of CCR5 by 873140 was extremely persistent with a rate const. for reversal of <0.004 h-1 (t1/2 > 136 h).  Coadministration studies of 873140 with the four other allosteric antagonists yielded data that are consistent with the notion that all five of these antagonists bind to a common allosteric site on the CCR5 receptor.  Although these ligands may have a common binding site, they do not exert the same allosteric effect on the receptor, as indicated by their differential effects on the binding of 125I-RANTES.  This idea is discussed in terms of using these drugs sequentially to overcome HIV viral resistance in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQkUJlzWK3HbVg90H21EOLACvtfcHk0lgUxm5DJQHrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFWmsLg%253D&md5=576b260ae1c12d5291451a8dadc6c0af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.008565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.008565%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DThe%2520CCR5%2520receptor-based%2520mechanism%2520of%2520action%2520of%2520873140%252C%2520a%2520potent%2520allosteric%2520noncompetitive%2520HIV%2520entry%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D1268%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pearlman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. M.</span><span> </span><span class="NLM_article-title">Novel software tools for chemical diversity</span> <span class="citation_source-journal">Persp. Drug Discovery Des.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">339</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1023%2FA%3A1027232610247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADyaK1cXksVantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=339-353&author=R.+S.+Pearlmanauthor=K.+M.+Smith&title=Novel+software+tools+for+chemical+diversity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel software tools for chemical diversity</span></div><div class="casAuthors">Pearlman, Robert S.; Smith, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9/10/11</span>
        (<span class="NLM_cas:issue">3D QSAR in Drug Design: Ligand/Protein Interactions and Molecular Similarity</span>),
    <span class="NLM_cas:pages">339-353</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 24 refs. is given including chem.-space concepts and diversity-related algorithms, BCUT (Burden, Chem. Abstr. Service, University of Texas) values, validation of chem.-space metrics, using low-dimensional metrics for diversity-related tasks, simple and biased diverse subset selection, identifying and filling in diversity voids, and comparing the diversities of 2 or more populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY_gw_7KVrArVg90H21EOLACvtfcHk0ljWP98Y9RvwXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVantLc%253D&md5=66a1de522730ef3b1c1d80d95c3e669a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1023%2FA%3A1027232610247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1027232610247%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26atitle%3DNovel%2520software%2520tools%2520for%2520chemical%2520diversity%26jtitle%3DPersp.%2520Drug%2520Discovery%2520Des.%26date%3D1998%26volume%3D9%26spage%3D339%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kazmierski, W.; Anderson, D. L.; Aquino, C. J.; Bifulco, N.; Boone, L. R.; Boros, E. E.; Chauder, B. A.; Chong, P. Y.; Duan, M.; Ferris, R. G.; Kenakin, T. P.; Koble, C. S.; Lang, D. G.; McLean, E.; McIntyre, M. S.; Peckham, J. P.; Spaltenstein, A.; Svolto, A. C.; Thompson, J. B.; Yang, H.; Youngman, M. K.; Wheelan, P. J.</span><span> </span><span class="NLM_article-title">Novel, potent and bioavailable CCR5 chemokine receptor small-molecule antagonists for HIV therapy: scaffold discovery and addressing hERG ion channel affinity in the process of optimizing potency and bioavailability</span>. <span class="NLM_conf-name">232nd ACS National Meeting</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sept. 10−14, 2006</span>, <span class="NLM_elocation-id">MEDI-297.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kazmierski%2C+W.%3B+Anderson%2C+D.+L.%3B+Aquino%2C+C.+J.%3B+Bifulco%2C+N.%3B+Boone%2C+L.+R.%3B+Boros%2C+E.+E.%3B+Chauder%2C+B.+A.%3B+Chong%2C+P.+Y.%3B+Duan%2C+M.%3B+Ferris%2C+R.+G.%3B+Kenakin%2C+T.+P.%3B+Koble%2C+C.+S.%3B+Lang%2C+D.+G.%3B+McLean%2C+E.%3B+McIntyre%2C+M.+S.%3B+Peckham%2C+J.+P.%3B+Spaltenstein%2C+A.%3B+Svolto%2C+A.+C.%3B+Thompson%2C+J.+B.%3B+Yang%2C+H.%3B+Youngman%2C+M.+K.%3B+Wheelan%2C+P.+J.+Novel%2C+potent+and+bioavailable+CCR5+chemokine+receptor+small-molecule+antagonists+for+HIV+therapy%3A+scaffold+discovery+and+addressing+hERG+ion+channel+affinity+in+the+process+of+optimizing+potency+and+bioavailability.+232nd+ACS+National+Meeting%2C+San+Francisco%2C+CA%2C+Sept.+10%E2%88%9214%2C+2006%2C+MEDI-297."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%26atitle%3DNovel%252C%2520potent%2520and%2520bioavailable%2520CCR5%2520chemokine%2520receptor%2520small-molecule%2520antagonists%2520for%2520HIV%2520therapy%253A%2520scaffold%2520discovery%2520and%2520addressing%2520hERG%2520ion%2520channel%2520affinity%2520in%2520the%2520process%2520of%2520optimizing%2520potency%2520and%2520bioavailability" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kazmierski, W. M.; Aquino, C. J.; Bifulco, N.; Boros, E. E.; Chauder, B. A.; Chong, P. Y.; Duan, M.; Deanda, F., Jr.; Koble, C. S.; Mclean, E. W.; Peckham, J. P.; Perkins, A. C.; Thompson, J. B.; Vanderwall, D.</span><span> </span><span class="NLM_article-title">Preparation of benzimidazolylazabicyclooctylethylpiperidines as CCR5 antagonists for the treatment of HIV infection</span>. Patent WO2004054974, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+M.+Kazmierski&author=C.+J.+Aquino&author=N.+Bifulco&author=E.+E.+Boros&author=B.+A.+Chauder&author=P.+Y.+Chong&author=M.+Duan&author=F.%2C+Jr.+Deanda&author=C.+S.+Koble&author=E.+W.+Mclean&author=J.+P.+Peckham&author=A.+C.+Perkins&author=J.+B.+Thompson&author=D.+Vanderwall&title=Preparation+of+benzimidazolylazabicyclooctylethylpiperidines+as+CCR5+antagonists+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26atitle%3DPreparation%2520of%2520benzimidazolylazabicyclooctylethylpiperidines%2520as%2520CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yang, H.; Kazmierski, W. M.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolidine and azetidine compounds as CCR5 antagonists</span>. Patent WO2004055016, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+Yang&author=W.+M.+Kazmierski&author=C.+J.+Aquino&title=Preparation+of+pyrrolidine+and+azetidine+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520pyrrolidine%2520and%2520azetidine%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Duan, M.; Kazmierski, W. M.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclylalkyl substituted cyclohexyl compounds as CCR5 antagonists</span>. Patent WO2004054581, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Duan&author=W.+M.+Kazmierski&author=C.+J.+Aquino&title=Preparation+of+heterocyclylalkyl+substituted+cyclohexyl+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520heterocyclylalkyl%2520substituted%2520cyclohexyl%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Aquino, C. J.; Chong, P. Y.; Duan, M.; Kazmierski, W. M.</span><span> </span><span class="NLM_article-title">Preparation of oxazine and morpholine derivatives as CCR5 antagonists</span>. Patent WO2004055011, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+J.+Aquino&author=P.+Y.+Chong&author=M.+Duan&author=W.+M.+Kazmierski&title=Preparation+of+oxazine+and+morpholine+derivatives+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520oxazine%2520and%2520morpholine%2520derivatives%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Peckham, J. P.; Aquino, C. J.; Kazmierski, W. M.</span><span> </span><span class="NLM_article-title">Preparation of aminoalkylaryl cyclopropyl compounds as CCR5 antagonists</span>. Patent WO2004055010, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+P.+Peckham&author=C.+J.+Aquino&author=W.+M.+Kazmierski&title=Preparation+of+aminoalkylaryl+cyclopropyl+compounds+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26atitle%3DPreparation%2520of%2520aminoalkylaryl%2520cyclopropyl%2520compounds%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Youngman, M.; Kazmierski, W. M.; Yang, H.; Aquino, C. J.</span><span> </span><span class="NLM_article-title">Preparation of indane compounds and analogs as CCR5 antagonists</span>. Patent WO2004055012, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Youngman&author=W.+M.+Kazmierski&author=H.+Yang&author=C.+J.+Aquino&title=Preparation+of+indane+compounds+and+analogs+as+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520indane%2520compounds%2520and%2520analogs%2520as%2520CCR5%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dostert, P.; Imbert, T.; Bucher, B.</span><span> </span><span class="NLM_article-title">β-3-Aminonortropane derivatives</span>. Fr. Demande Appl. No. 79 00971, <span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=P.+Dostert&author=T.+Imbert&author=B.+Bucher&title=%CE%B2-3-Aminonortropane+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DP.%26atitle%3D%25CE%25B2-3-Aminonortropane%2520derivatives%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Harrison, T.; Swain, C. J.</span><span> </span><span class="NLM_article-title">Preparation of 3,3-disubstituted piperidines for treating the conditions associated with an excess of tachykinins</span>. U.S. Patent 5807865, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+Harrison&author=C.+J.+Swain&title=Preparation+of+3%2C3-disubstituted+piperidines+for+treating+the+conditions+associated+with+an+excess+of+tachykinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DPreparation%2520of%25203%252C3-disubstituted%2520piperidines%2520for%2520treating%2520the%2520conditions%2520associated%2520with%2520an%2520excess%2520of%2520tachykinins%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grugni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigolio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassallo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, C.</span><span> </span><span class="NLM_article-title">A reliable and efficient synthesis of SR 142801</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">2307</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=2307-2310&author=G.+A.+M.+Giardinaauthor=M.+Grugniauthor=R.+Rigolioauthor=M.+Vassalloauthor=K.+Erhardauthor=C.+Farina&title=A+reliable+and+efficient+synthesis+of+SR+142801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26aulast%3DGrugni%26aufirst%3DM.%26aulast%3DRigolio%26aufirst%3DR.%26aulast%3DVassallo%26aufirst%3DM.%26aulast%3DErhard%26aufirst%3DK.%26aulast%3DFarina%26aufirst%3DC.%26atitle%3DA%2520reliable%2520and%2520efficient%2520synthesis%2520of%2520SR%2520142801%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D2307%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Emonds-Alt, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaulme, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miloux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poncelet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proietto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breliere, J. C.</span><span> </span><span class="NLM_article-title">SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">PL27</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=PL27-32&author=X.+Emonds-Altauthor=D.+Bichonauthor=J.+P.+Ducouxauthor=M.+Heaulmeauthor=B.+Milouxauthor=M.+Ponceletauthor=V.+Proiettoauthor=D.+Van+Broeckauthor=P.+Vilainauthor=G.+Neliatauthor=P.+Soubrieauthor=G.+Le+Furauthor=J.+C.+Breliere&title=SR+142801%2C+the+first+potent+non-peptide+antagonist+of+the+tachykinin+NK3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmonds-Alt%26aufirst%3DX.%26aulast%3DBichon%26aufirst%3DD.%26aulast%3DDucoux%26aufirst%3DJ.%2BP.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DMiloux%26aufirst%3DB.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DProietto%26aufirst%3DV.%26aulast%3DVan%2BBroeck%26aufirst%3DD.%26aulast%3DVilain%26aufirst%3DP.%26aulast%3DNeliat%26aufirst%3DG.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DBreliere%26aufirst%3DJ.%2BC.%26atitle%3DSR%2520142801%252C%2520the%2520first%2520potent%2520non-peptide%2520antagonist%2520of%2520the%2520tachykinin%2520NK3%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D56%26spage%3DPL27%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">3103</span> <span class="NLM_lpage">3106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=3103-3106&author=D.+Kimauthor=L.+Wangauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+E.+Finkeauthor=B.+Oatesauthor=M.+MacCossauthor=S.+G.+Millsauthor=L.+Malkowitzauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=M.+S.+Springerauthor=D.+Hazudaauthor=M.+Millerauthor=J.+Kesslerauthor=R.+Danzeisenauthor=G.+Carverauthor=A.+Carellaauthor=K.+Holmesauthor=J.+Linebergerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Design%2C+synthesis%2C+and+SAR+of+heterocycle-containing+antagonists+of+the+human+CCR5+receptor+for+the+treatment+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DOates%26aufirst%3DB.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520of%2520heterocycle-containing%2520antagonists%2520of%2520the%2520human%2520CCR5%2520receptor%2520for%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D3103%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chauder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabet, E.</span><span> </span><span class="NLM_article-title">Synthesis of 4-substituted piperidines via a mild and scalable two-step Cu2O-mediated decarboxylation of cyanoesters</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">36</span> <span class="NLM_fpage">279</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1080%2F00397910500374971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmtl2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=279-284&author=B.+Chauderauthor=E.+Borosauthor=K.+Duauthor=W.+Kazmierskiauthor=C.+Kobleauthor=J.+Thompsonauthor=E.+Tabet&title=Synthesis+of+4-substituted+piperidines+via+a+mild+and+scalable+two-step+Cu2O-mediated+decarboxylation+of+cyanoesters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-substituted piperidines via a mild and scalable two-step Cu2O-mediated decarboxylation of cyanoesters</span></div><div class="casAuthors">Chauder, Brian; Boros, Eric; Du, Kien; Kazmierski, Wieslaw; Koble, Cecilia; Thompson, James; Tabet, Elie</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A four-step, high-yielding, kilogram-scale protocol to prep. piperidyl-acetaldehyde deriv. is reported.  The key reaction is a mild, two-step Cu2O-mediated decarboxylation of piperidyl-cyanoester that proceeds in excellent yield.  The general applicability of this methodol. was also explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk6gg6XLzy7Vg90H21EOLACvtfcHk0liJOlUQtZD2SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmtl2juw%253D%253D&md5=b46a6e1f9e37b814dbae34b3d73f0891</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00397910500374971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500374971%26sid%3Dliteratum%253Aachs%26aulast%3DChauder%26aufirst%3DB.%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DKoble%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DTabet%26aufirst%3DE.%26atitle%3DSynthesis%2520of%25204-substituted%2520piperidines%2520via%2520a%2520mild%2520and%2520scalable%2520two-step%2520Cu2O-mediated%2520decarboxylation%2520of%2520cyanoesters%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D279%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chauder, B. A.; Anderson, D.; Aquino, C. J.; Bifulco, N.; Boone, L. R.; Boros, E. E.; Chong, P. Y.; Du, K. S.; Duan, M.; Ferris, R. G.; Kazmierski, W. M.; Kenakin, T. P.; Koble, C. S.; Lang, D. G.; Peckham, J. P.; Spaltenstein, A.; Thompson, J. B.; Youngman, M. K.; Wheelan, P. J.</span><span> </span><span class="NLM_article-title">Discovery and design of potent piperidine-based CCR5 antagonists for the potential treatment of HIV-1 infection</span>. <span class="NLM_conf-name">232nd ACS National Meeting</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sept. 10−14, 2006</span>,  <span class="NLM_fpage">MEDI-242</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chauder%2C+B.+A.%3B+Anderson%2C+D.%3B+Aquino%2C+C.+J.%3B+Bifulco%2C+N.%3B+Boone%2C+L.+R.%3B+Boros%2C+E.+E.%3B+Chong%2C+P.+Y.%3B+Du%2C+K.+S.%3B+Duan%2C+M.%3B+Ferris%2C+R.+G.%3B+Kazmierski%2C+W.+M.%3B+Kenakin%2C+T.+P.%3B+Koble%2C+C.+S.%3B+Lang%2C+D.+G.%3B+Peckham%2C+J.+P.%3B+Spaltenstein%2C+A.%3B+Thompson%2C+J.+B.%3B+Youngman%2C+M.+K.%3B+Wheelan%2C+P.+J.+Discovery+and+design+of+potent+piperidine-based+CCR5+antagonists+for+the+potential+treatment+of+HIV-1+infection.+232nd+ACS+National+Meeting%2C+San+Francisco%2C+CA%2C+Sept.+10%E2%88%9214%2C+2006%2C+MEDI-242."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChauder%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520and%2520design%2520of%2520potent%2520piperidine-based%2520CCR5%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520HIV-1%2520infection%26spage%3DMEDI-242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span> </span><span class="NLM_article-title">Development of a High-Throughput Viral-Free Assay for the Measurement of CCR5-Mediated HIV/Cell Fusion</span> <span class="citation_source-journal">Recept.Channels</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">117</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1080%2F10606820308248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=12916472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVGjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=117-123&author=S.+Jenkinsonauthor=D.+McCoyauthor=S.+Kernerauthor=R.+Ferrisauthor=W.+Lawrenceauthor=T.+Foxauthor=C.+Smith&title=Development+of+a+High-Throughput+Viral-Free+Assay+for+the+Measurement+of+CCR5-Mediated+HIV%2FCell+Fusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a High-Throughput Viral-Free Assay for the Measurement of CCR5-Mediated HIV/Cell Fusion</span></div><div class="casAuthors">Jenkinson, Stephen; McCoy, David; Kerner, Sandy; Ferris, Rob; Lawrence, Wendell; Fox, Tony; Smith, Chari</div><div class="citationInfo"><span class="NLM_cas:title">Receptors and Channels</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">RCHAE4</span>;
        ISSN:<span class="NLM_cas:issn">1060-6823</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">M-tropic HIV strains gain access to their host cell via interaction of the viral envelope protein gp120 with the CCR5 coreceptor and CD4 located on the host cell.  Inhibition of this event has been shown to reduce viral fusion and entry into cells in vitro.  In the present study we describe the development of a novel cell/cell fusion assay that both mimics the viral/cell fusion process and allows quantification of this event.  The assay has been characterized both biochem., using selective antibodies, and pharmacol., using selective CCR5 antagonists, and has been shown to be selective for examg. the interaction of viral gp120 with hCCR5/hCD4.  In addn., compd. pIC50 data obtained from this cell/cell fusion assay correlates well (r2 = 0.7274) with data obtained from an HIV-1 replication assay.  Furthermore, this assay has the added ability to simultaneously det. compd. toxicity, thus allowing rapid detn. of active, non-toxic compds.  In conclusion, the cell/cell fusion assay developed has been demonstrated to be a suitable surrogate assay that can be used to assess the effects of compds. on gp120/CCR5/CD4 mediated viral fusion into host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEqHHnl0c5bVg90H21EOLACvtfcHk0lhpTp6LQoIP4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVGjurw%253D&md5=a0e53f50eb24a2c4c44d35ff7e16e5ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F10606820308248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10606820308248%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DMcCoy%26aufirst%3DD.%26aulast%3DKerner%26aufirst%3DS.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DFox%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520High-Throughput%2520Viral-Free%2520Assay%2520for%2520the%2520Measurement%2520of%2520CCR5-Mediated%2520HIV%252FCell%2520Fusion%26jtitle%3DRecept.Channels%26date%3D2003%26volume%3D9%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, L.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">3147</span> <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800598a&amp;key=10.1128%2FAAC.00401-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800598a&amp;key=17620375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800598a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVais73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3147-3154&author=R.+Hazenauthor=R.+Harveyauthor=R.+Ferrisauthor=C.+Craigauthor=P.+Yatesauthor=P.+Griffinauthor=J.+Millerauthor=I.+Kaldorauthor=J.+Rayauthor=V.+Samanoauthor=E.+Furfineauthor=A.+Spaltensteinauthor=M.+Haleauthor=R.+Tungauthor=M.+St.+Clairauthor=M.+Hanlonauthor=L.+Boone&title=In+vitro+antiviral+activity+of+the+novel%2C+tyrosyl-based+human+immunodeficiency+virus+%28HIV%29+type+1+protease+inhibitor+brecanavir+%28GW640385%29+in+combination+with+other+antiretrovirals+and+against+a+panel+of+protease+inhibitor-resistant+HIV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV</span></div><div class="casAuthors">Hazen, Richard; Harvey, Robert; Ferris, Robert; Craig, Charles; Yates, Phillip; Griffin, Philip; Miller, John; Kaldor, Istvan; Ray, John; Samano, Vincente; Furfine, Eric; Spaltenstein, Andrew; Hale, Michael; Tung, Roger; St. Clair, Marty; Hanlon, Mary; Boone, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-3154</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brecanavir, a novel tyrosyl-based arylsulfonamide, high-affinity, human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI), has been evaluated for anti-HIV activity in several in vitro assays.  Preclin. assessment of brecanavir indicated that this compd. potently inhibited HIV-1 in cell culture assays with 50% effective concns. (EC50s) of 0.2 to 0.53 nM and was equally active against HIV strains utilizing either the CXCR4 or CCR5 coreceptor, as was found with other PIs.  The presence of up to 40% human serum decreased the anti-HIV-1 activity of brecanavir by 5.2-fold, but under these conditions the compd. retained single-digit nanomolar EC50s.  When brecanavir was tested in combination with nucleoside reverse transcriptase inhibitors, the antiviral activity of brecanavir was synergistic with the effects of stavudine and additive to the effects of zidovudine, tenofovir, dideoxycytidine, didanosine, adefovir, abacavir, lamivudine, and emtricitabine.  Brecanavir was synergistic with the nonnucleoside reverse transcriptase inhibitor nevirapine or delavirdine and was additive to the effects of efavirenz.  In combination with other PIs, brecanavir was additive to the activities of indinavir, lopinavir, nelfinavir, ritonavir, amprenavir, saquinavir, and atazanavir.  Clin. HIV isolates from PI-experienced patients were evaluated for sensitivity to brecanavir and other PIs in a recombinant virus assay.  Brecanavir had a <5-fold increase in EC50s against 80% of patient isolates tested and had a greater mean in vitro potency than amprenavir, indinavir, lopinavir, atazanavir, tipranavir, and darunavir.  Brecanavir is by a substantial margin the most potent and broadly active antiviral agent among the PIs tested in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplFzzXvQJ9rVg90H21EOLACvtfcHk0lhpTp6LQoIP4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVais73F&md5=a84fb4b36143fb6c9e92db4895ad1d9d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.00401-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00401-07%26sid%3Dliteratum%253Aachs%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DR.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DI.%26aulast%3DRay%26aufirst%3DJ.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DFurfine%26aufirst%3DE.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DHale%26aufirst%3DM.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DSt.%2BClair%26aufirst%3DM.%26aulast%3DHanlon%26aufirst%3DM.%26aulast%3DBoone%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520of%2520the%2520novel%252C%2520tyrosyl-based%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520type%25201%2520protease%2520inhibitor%2520brecanavir%2520%2528GW640385%2529%2520in%2520combination%2520with%2520other%2520antiretrovirals%2520and%2520against%2520a%2520panel%2520of%2520protease%2520inhibitor-resistant%2520HIV%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3147%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800598a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-20%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm800598a%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800598a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                293KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679965571db23d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
